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CHAPTER I 
INTRODUCTION 
An Overview of Energy Conservation in Mitochondria 
Aerobic organisms obtain most of their energy for cell metabolism and 
biosynthesis through the citric acid cycle and the electron transport system through 
mitochondria. NADH and succinate generated by citric acid cycle are oxidized in the 
electron transfer chain. The free energy liberated in these oxidations is partially conserved 
in the phosphoanhydride bonds of A TP. These reactions occur within discrete 
multienzyme respiratory chain complexes located in the inner mitochondrial membrane. 
These multienzyme respiratory chain complexes are: NADH-ubiquinone reductase 
(Complex 1), succinate-ubiquinone reductase (Complex II), ubiquinol-cytochrome c 
reductase (Complex III) and cytochrome c oxidase (Complex IV). 
NADH and succinate donate electrons to NADH-ubiquinone reductase and 
succinate-ubiquinone reductase respectively. Electron transfer proceeds from NADH-
ubiquinone reductase and succinate-ubiquinone reductase to coenzyme Q. Reduced 
coenzyme Q reduces, in turn, cytochrome c via ubiquinol-cytochrome c reductase. 
Reduced cytochrome cis then oxidized by cytochrome c oxidase, which finally reduces 
oxygen to water. The oxidation of NADH is coupled to the phosphorylation of three 
moles of ADP and succinate to two moles of ADP (Fig. 1). 
In 1961 Mitchell (1) proposed a chemiosmotic hypothesis, in which an 
electrochemical gradient across the membrane provides the driving force for 
phosphorylation of ADP. The eletrochemical gradient is created by asymmetric ejection of 
1 
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Fig. 1. Flow of Electrons in Respiration Chain and the Sites of ATP Synthesis 
protons into the intermembrane space. The driving force for gradient formation is the 
energy released from the redox reactions catalyzed by the respiratory chain complexes. 
The driving force has two components (2): pH gradient (dpH) and membrane potential 
(d Y). The sum of these two terms is called the proton motive force (M>). The 
relationship of dpH, d Y and M> can be described by the following formula analogous to 
the Nemst equation. 
M> = d Y - 2.303 (RT/F) dpH 
3 
The term M>, whose unit is volts, corresponds toE'; dY is analogous to Eo'; and 
the term -2.303 (RT/F) ~pH is the Nernst potential,also in volts,that is generated by the 
ejection of protons into the intermembrane space. 
In the chemiosmotic hypothesis the proton gradient is directly coupled to A TP 
synthesis. The membrane sector of the mitochondrial A TPase is a conduit for protons and 
the flow of protons back into the mitochondria through A TPase alters the active site of the 
A TPase leading to A TP synthesis (Fig 2) (3). 
It has been demonstrated that the three coupling sites of the respiratory chain at 
NADH-ubiquinone reductase, ubiquinol-cytochrome c reductase and cytochrome c 
reductase can each generate an electrochemical potential across the membrane. Ubiquinol-
cytochrome c reductase of the mitochondrial respiratory chain catalyzes electron transfer 
from ubiquinol to cytochrome c which is coupled to A TP synthesis. In agreement with the 
chemiosmotic theory of energy coupling, ubquinol-cytochrome c reductase catalyzes the 
electrogenic translocation of protons across the membrane during the transfer of electron 
down to the complex N. The overall reaction is as follows: 
QH2 + 2 cyt. c3+ + 2 H+(M side)--Q + 2 cyt. c2+ + 4 H+(C side) 
As seen in the above reaction, four protons appear on the cytoplasmic side of the 
inner mitochondrial membrane with the transfer of 2 electrons. Two of the four protons 
M-aid• 
Fig. 2. Flow of Protons through Coupling Factors in a 
Submitochondrial Particle 
4 
are from the oxidation of QH2 by cytochrome c, the other two from the electronegative, 
matrix side of the inner mitochondrial membrane. Apparently ubiquinol-cytochrome c 
reductase not only functions as an electron carrier, but also appears to be involved directly 
in transmembrane proton pumping. Although much progress on the structure studies of 
ubiquinol-cytochrome c reductase has been achieved, the mechanism of proton and 
electron transfer in this complex is still far from being undersdood. The role of 
ubiquinones, especially the protein-bound form, in electron and proton transfer reactions 
in bovine heart mitochondrial ubiquinol-cytochrome c reductase is the primary concern of 
this thesis. 
The Chemical Composition of Ubiquinol-cytochrome c 
Reductase of Bovine Heart Mitochondria 
Ubiquinol-cytochrome c reductase of bovine heart mitochondria, the segment of 
energy coupling site 2, is a multi protein complex, which is composed of more protein 
subunits than ubiquinol-cytochrome c reductase of chromatophores and b6f complex of 
chloroplasts. It consists of 11 subunits, 3 of which are carrying the redox centers. 
5 
Certain amounts of phospholipids and ubiquinone are contained in fully active isolated 
ubiquinol-cytochrome c reductase. In the past 25 years since the first reported purification 
and description of ubiquinol-cytochrome c reductase ( 161 ), much effort has been made in 
the purification of the enzyme, isolation and identification of the individial subunits, as 
well as the arrangement of each subunit in the respiratory chain. Although further study of 
composition and function of the reductase is needed, the outline about the chemical 
composition is clear. 
Preparations of the mitochondrial ubiquinol-cytochrome c reductase obtained by 
different procedures are similar in composition. It usually contains 8 nmoles of 
cytochrome band 4-5 nmoles of cytochrome q per mg. protein (4). The high purity 
ubiquinol-cytochrome c reductase was prepared (5) from succinate-cytochrome c 
6 
reductase. The composition of the high purity ubiquinol-cytochrome c reductase is shown 
in Table I. 
The lipid content in the mitochondrial preparations depends on what kind of 
solubilizing detergents is used in the process. If bile salts are used, about 0.2 mg. lipid 
per mg. protein is retained, which corresponds to about 50 lipid molecules per cytochrome 
q (5-8). The major phospholipids are cardiolipin, phosphatidylethanolamine and 
phosphatidylcholine present in a molar ratio of about 10:20:20 (9). 
Subunit Structure 
The subunit structure of ubiquinol-cytochrome c reductase of bovine heart 
mitochondria has been extensively studied. When ubiquinol-cytochrome c reductase is 
subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) using the Weber and 
Osborn system, seven bands are found with apparent molecular weights of 53, 50, 37, 
30, 28, 17, and 15 Kd (8). The 37 and 17Kd subunits were assigned to be associated 
with b cytochrome, the 30 Kd subunit was cytochrome q, whereas the 28 Kd subunit 
was iron-sulfur protein. In 1986 Schagger et al. (10) separated all the 11 subunits of 
ubiquinol-cytochrome c reductase using a high resolution SDS-PAGE system and 
suggested an assignment of each polypeptide(Fig.3). In 1988 based on theN-terminal 
analysis of each subunit, Gonzalez-halphen et al. proposed a new assignment of the 11 
subunits (54). According to their assignment, bands VII and VIlla in Fig. 3 should be the 
same protein because they have an identical N-terminal GRQFG. These two bands on the 
gel are eletrophoretic variants of the same subunit. It might be due to incomplete reduction 
of the disulfide bonds. These two bands were designated as VIla and VIIb. Since there 
VITia was absent in Fig. 3, VIIIb was assigned as VIII. However, there is some 
controversy concerning the assignment and the functions of the small polypeptides. For 
instance, subunit VI in figure 3 was reported as Q-binding protein (QPc) (158), but 
TABLE I 
THE COMPOSIDON OF HIGH PURITY UBIQUINOL-CYTOCHROME 
cREDUCTASE 
Component Concentration (nmol/mg protein) 
cytochrome b 10- 10.5 
cytochrome c 1 5.7 - 6.0 
iron-sulfur protein 6.6- 7.2 
ubiquinone 2-3 
phospholipids 250 
7 
• 
band prottin kDa 
-
• 
I core protein I 49 
II core prottin II 47 
.. 
-
Ill cytochrome b 43.7 
IV cytochrome c 1 27.9 
• iron-sulfu~ prote1n 25 
£': ... : -.. . 
r 
-
v: I)-binding protein i3.4 
-
VII 11 kOa protein 11 
? -.: ~ VIII hinge protein 9.2 
IX OCCO-binding protein 8.0 
X 7.2 kDa protein 7.2 
XI 6.4 kOa protein 6.4 
Fig. 3. SDS-PAGE of the Subunits of Ubiquinol-Cytochrome c 
Reductase from Beef Mitochondria. Outer left lane, c1 
subcomplex; outer right lane, ubiquinol-cytochrome c 
reductase isolated in Triton X -1 00; middle lanes, corres-
ponding isolated subunits. 
8 
actually it is not QPc. The real QPc is subunit VII (chapter II). The function of subunit 
VI has not been confirmed. 
Redox Components 
9 
There are five redox components in ubiquinol-cytochrome c reductase of beef heart 
mitochondria. They are two b cytochromes (b566· b562), cytochrome c1, iron sulfur 
protein, and ubiquinone. Cytochrome b, c1 and iron sulfur protein are present in the ratio 
of 2:1:1. The amount of ubiquinone is variable in different preparations of ubiquinol-
cytochrome c reductase. However, it was reported that when the ratio of ubiquinone to 
cytochrome c1 was 1:1, the highest activity was observed (117). 
Cytochrome b. Cytochromes b are thermodynamically heterogeneous. There are 
at least two b cytochromes with different midpoint potentials and absorption spectra 
present in ubiquinol-cytochrome c reductase (12). The one with midpoint potential of +93 
mV corresponds to a component with an a-peak at 562 nm. Another one with midpoint 
potential of +34m V corresponds to a component with a a-peak at 566 nm (13). The 
potential of both cytochromes b exhibit ph~spholipid dependence (141) and pH-
dependence in the physiological range(14); Cytochrome b has been isolated from beef 
heart mitochondria(15,16). The isolated protein shows only a single a-peak at 562 nm. 
The molecular weight of isolated cytochrome b (30-37kd) estimated by electrophoresis is 
not reliable because it was reported that the detergent binding property of the protein is 
abnormal. Also it is difficult to calculate the molecular weight from the heme content, as 
heme is easily lost during purification in the presence of detergent. The molecular weight 
calculated from the sequence of the gene is 42,540 (157). EPR studies of the cytochrome 
b of ubiquinol-cytochrome c reductase (17) have indicated that both b type hemes are 
presebt at low spin status. The effect of externally added dysprosium complexes on the 
EPR spin relaxation of the two heme g=3.8 (bL) and g=3.4 (bH) signals was studied 
(55). The results of the EPR study of the hemes, together with the structure prediction 
derived from the amino acid sequences of cytochrome b (123, 124), have led to the 
proposal that the two hemes are sandwiched between the membrane-spanning helices II 
and V (or IV), and that the Fe-Fe distance is 21A (Fig.4) (55). 
Cytochrome C}. Cytochrome q is a distinct functional component of ubiquinol-
cytochrome c reductase. Cytochrome q of beef heart mitochondrial ubiquinol-
cytochrome c reductase has been isolated by several groups (18, 162, 160). The 
absorption spectrum of the reduced cytochrome c1 possessed maxima at 552.5, 530, 
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522.5, 512,417,317 and 276 nm, and the oxidized form at 558,522,411,355 and 276 
nm. Isolated cytochrome c 1 contains 25 nmoles heme per mg of protein and shows two 
bands in SDS-PAGE with apparent molecular weights of30 and 15 Kd, respectively (18). 
The c type heme is covalently attached to the 30 Kd subunit. The 15 Kd protein subunit is 
the so called hinge protein, the function of which is still not very clear. The midpoint 
potential of cytochrome q is between +225 and +245mV(18-20). It is almost identical to 
the potential of cytochrome c and appears to be significantly more negative then that of the 
iron sulfur protein (+280 mV). In iron sulfur protein depleted ubiquinol-cytochrome c 
reductase cytochrome q is oxidizable by cytochrome c plus cytochrome c oxidase 
indicating that q is a terminal electron acceptor in ubiquinol-cytochrome c reductase and 
electron donor for cytochrome c (21-23). 
Iron Sulfur Protein. The iron sulfur protein of ubiquinol-cytochrome c reductase 
was first discovered in mitochondria by Rieske (25). It has been isolated in a 
reconstitutively active form from beef heart mitochondria (26,27). It is a 25 kD 
polypeptide containing an iron-sulfer cluster of the 2Fe-2S type. Its midpoint potential has 
been determined to be + 280 m V. Its reduced form is paramagnetic and exhibits an 
electron paramagnetic resonance (EPR) spectrum with a central resonance at g=1.90 (27). 
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Fig. 4. Location of the Two b Type Cytochromes in Ubiquinol-Cytochrome c ReductaSe 
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This EPR spectrum can be affected by the redox status of ubiquinone (28,32) and 
quinone-like inhibitors (33-37). 
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The function of iron-sulfur protein in electron transfer in ubiquinol-cytochrome c 
reductase has been confirmed by examining oxidation-reduction reactions of cytochrome b 
and C} in the presence and absence of iron-sulfur protein and antimycin. In the presence 
of antimycin iron-sulfur protein is required for the reduction of both cytochrome b and c 1· 
In the absence of antimycin the reduction of cytochrome b does not require iron-sulfur 
protein, but the reduction of cytochrome c1 does. These finding provide an evidence in 
support of a branched cycle pathway of electron transfer in ubiquinol-cytochrome c 
reductase. 
UbiQuinone. Ubiquinone (UQ) is the only small lipophilic molecule in the 
mitochondrial respiratory chain, which is oxidized and reduced through reactions which 
unequivocally involve net release and uptake of protons. The structure (Fig. 5.) which is 
obviously related to its function is the benzoquinone ring which can undergo oxidation-
reduction. Also the ring substituents can give ubiquinone additional properties which are 
important to its biological function. The length and the flexibility of the alkyl side chain 
can also affect the activity of ubiquinone as electron acceptor, donor and mediator in 
electron transfer reactions (82). Ubiquinone occurs in about tenfold molar excess 
compared to the individual cytochromes. This fact has led to the idea that Q is a mobile 
component (38-40) which can move freely within phospholipid bilayer and shuttles 
electrons among the electron-transfer complexes. Based on this idea, the hypothesis of' 
pool function of Q' has been proposed ( 41 ). The amount of ubiquinone contained in 
ubiquinol-cytochrome c reductase varies with different preparations. It was reported (4) 
that in preparations of mitochondrial ubiquinol-cytochrome c reductase, up to one 
equivalent of ubiquinone per cytochrome c 1 is carried along if Triton X -100 is avoided 
during purification. Even highly purified preparations of ubiquinol-cytochrome c 
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Fig. 5. The Structure of Ubiquinone CUQlQ) 
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reductase still contain significant amounts of ubiquinone which can not easily be removed 
Q (44). The redox potential of the ubiquinol-ubiquinone overall reaction and of the two 
half reactions in ethanolic solution at pH 7 were determined [E'(QHz/Q)=70 mV), 
E'(QHz/Q-)=380 mV, E'(Q-/Q)=-240 mV] (4). Binding of ubiquinone to the ubiquinol-
cytochrome c reductase complex might change the redox potential span between the two 
half reactions, as well as the potential of the overall reaction. 
Topological Arrangement of the Subunits. The topographical arrangement of the 
subunits in ubiquinol-cytochrome c reductase has been extensively studied and several 
techniques have been used in these studies. The techniques employed are crosslinking, 
radioactive labeling (45-51) and paramagnetic probe (52, 53). 
In 1988 Gonzalez-halpgen et a1 proposed a topological arrangement of the whole 
complex based on their own and other's experiments (Fig. 6) (54). It was found that 
cytochrome b was labeled 20 fold more heavily than other subunits when ubiquinol-
cytochrome c reductase was incorporated into membrane and treated with 3-
(trifluoromethyl)-3-(m-[ 125I]iodophenyl)diazirine. This indicates that cytochrome b is the 
predominent bilayer intercalated part of ubiquinol-cytochrome c reductase. Studies by 
protease digestion and crosslinking experiments confirm that iron-sulfur protein is on the 
cytoplasmic side of the membrane and peripherally located, possiblly bound to cytochrome 
b through hydrophobic interaction. Cross-linking data indicate hinge protein and subunit 
X are near neighbors of cytochrome q. Two core proteins and subunit VI were proved 
to be neighbors and located on theM side by cross-linking and protease digestion 
experiments. 
The excess ubiquinone is largely situated in the hydrophobic membrane core and 
called ubiquinone pool which functions as a redox buffer (55). 
1l I 
Fig. 6. Topography of Ubiquinol-Cytochrome c Reductase in 
Mitochondrial Electron Transfer Membrane. M and C refer to 
matrix and cytoplasmic side of the inner mitochondrial 
membrane. For the assignment of each subunit, see Fig. 3. 
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Proposed Mechanism of Electron Transfer 
in Ubiquinol-Cytochrome c Reductase 
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Because of experimental expendiency, electron-transfer processes in ubiquinol-
cytochrome c reductase have been studied principally in terms of the redox components of 
the complex, namely cytochrome b, q and the iron-sulfur center. Due to their visibility 
by spectroscopic methods coupled with electrochemical measurements, the electron-
transfer relationships among these subunits have been studied extensively. Several 
hypotheses have been proposed to explain the experimental pheomena concerning the 
electron and proton transfer in ubiquinol-cytochromec reductase. These hypotheses are: 
protonmotive ubiquinone cycle (Q cycle) originally proposed by Mitchell (42,43) and later 
modified by Trumpower (56,57); cytochrome b cycle (b cycle) proposed by Wikstrom and 
Krab (58); semiquinone cycle (SQ cycle)-- a modified b cycle proposed by Wikstrom and 
Saraste (59); double Q cycle proposed by Slater and his co-workers (87). At present the Q 
cycle mechanism is received a greatest attention because it can explain a number of 
phenomena related to electron transfer in ubiquinol-cytochrome c reductase, such as two 
distinct ubisemiquinone radicals, the oxidant induced cytochrome b reduction,and the 
stoichiometry of vectorial proton translocation with an H+/e- ratio of 2. 
0-cycle 
The pathway of electron and proton transfer in ubiquinol-cytochrome c reductase 
predicted by the protonmotive Q-cycle is shown in Fig. 7. There are two reaction centers, 
o center and i center, for ubiquinone to be oxidized and reduced. Ubiquinol is oxidized at 
the o center to ubisemiquinone radical with one electron going to iron-sulfur protein en 
route to cytochrome ct. two protons are released to the C side of the membrane. The 
ubisemiquinone radical thus formed reduces cytochrome b-566 (bL)· The electron from 
reduced cytochrome b-566 is then transferred to cytochrome b-562 (bH), which in tum 
reduces ubiquinone at i center to ubisemiquinone radical. The ubisemiquinone radical 
2H+ 
c 
,, ..... s .. ,~ 
, . . 
J 
~ ... 
b·S66 OH2 
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1 
b·562 
M 
Fig. 7. Protonmotive Q Cycle Mechanism for Electron Transfer 
through Ubiquinol-Cytochrome c Reductase 
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produced then gets one electon from succinate dehydrogenase and picks up two protons 
from matrix side to become ubiquinol. In the whole cycle for one electron going through 
ubiquinol-cytochrome c reductase, two protons are translocated from the M side to the C 
side of the innermitochondrial membrane. 
Inhibitors ofUbiquinol-Cytochrome c Reductase 
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A number of specific inhibitors have long been known to inhibit electron transport 
through ubiquinol-cytochrome c reductase (Table IT). They inhibit the reduction of 
ubiquinone or the oxidation of ubiquinol by blocking of different redox components. 
Studies of the inhibitory natures of these inhibitors provide a valuable approach to the 
elucidation of the mechanism of electron transfer in ubiquinol-cytochrome c reductase. 
According to the Q cycle mechanism, there are three inhibition sites in ubiquinol-
cytochrome c reductase as shown in Fig. 8. Accordingly, the three classes of inhibitors 
have been classified: (a), antimycin-like inhibitors, including antimycin, funiculosin and 2-
n-heptyl-4-hydroxyquinolin-N-oxide(HQNO); (b), MOA-type inhibitors, characterized by 
a reactive methoxyacrylate moiety in the molecule, including myxothiazol, mucidin and 
stigmatellin; and (c), quinone-like inhibitors including 5-Undecyl-6-Hydroxy-4.7-
dioxybenzothiazole (UHDBT), undecylhydroxynaphthoquinone and 
heptadecylmercaptohydroxyquinolinequinone (73). 
Antimycin 
Antimycin is a very potent inhibitor of ubiquinol-cytochrome c reductase and the 
most extensively studied inhibitor of respiration . A one to one ratio of amtimycin to 
cytochrome q completely abolishes the enzymatic activity ofubiquinol-cytochrome c 
reductase (83). It causes a red-shift of the alpha peak of cytochrome b-562 by 1.5 nm, 
without affecting the peak of b-566. It causes the line shift of b-562 EPR spectrun 
without changing the EPR spectrum of b-566 (64). It was also found that antimycin 
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TABLE ll 
INHIBITORS OF ELECI'RON TRANSFER IN MITOCHONDRIAL 
UBIQUINOL-CYTOCHROME c REDUCfASE 
Inhibitor Structure 
Antimycin o· "-( ):! OH g o-c o-c'N r c-~ - 1oof '6- M (CH2)n-CHJ 
~ H3C 
Funic:ulosin 
HO 
HQNO 
(bcptylhydroxyquinoline·N-oxidc) 
Myxothiazol 
Sttobilurin A 
(mucidin l 
StiplatclliD A 
0 
HJ 
Formu1ar Ref 
CaH..NA 144,145 
C,H.,NO. 146,147 
148 
149,150 
151 
152 
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TABLE ll (Continued) 
UHDBT 0 
(undecylhydroxydioxobenzothiazolcl S*OH C..H!'NO,S 111,153 <. I I 
N (CH2),o-CHJ 
0 o;:OH 154 UHNQ C:.H.O, (UDdec:yJhydroxynapbthoquinooc) «:~10-CH3 
0 
IIMHQQ' o):OH C.H,.NO,S 155 (lleptMec:ylmercapaobydroxyquinoliDe 
S-(CH2J,&-CHJ quiaoae) 
0 
N\ide,'l'-
center i 
center 2 
Pside,lf+ 
Fig. 8. Inhibitory Sites in Ubiquinol-Cytochrome c Reductase 
According to Q Cycle Mechanism 
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inhibits the oxidation of cytochrome band stimulates the oxidant-induced reduction of b 
cytochromes (65). These results together with the observation of the abolishment of the 
EPR signal of the ubisemiquinone radical by antimycin indicate that antimycin binds to 
center i or in its proximity and therefore blocks electron transfer between b-562 and the 
Q/QH couple (43), it is possibly that antimycin lowers the stabilization of 
ubisemiquinone by b-562 (11) or a closely associated peptide (66). 
Myxothiazol 
22 
Myxothiazol is an antibiotic which blocks mitochondrial respiration in ubiquinol-
cytochrome c reductase segment of the respiration chain (67). The doses required for 50% 
inhibition of enzymatic activity are 1 mol myxothiazol per mole of cytochrome c1 (4). It 
blocks the reduction of cytochrome b via an antimycin-insensitive pathway and causes a 
red shift of the a.-peak of cytochrome b-566 (68). When antimycin and myxothiazol are· 
added together to ubiquinol-cytochrome c reductase,the two b-heme centers are completely 
shielded against electrons. This result seems to match the probability of a linear sequence 
of the two heme b centers in the path of electron flow with two ubiqunone binding sites, 
one for each heme center (68) (Fig 9). However, further study (69) found that 
myxothiazol had effects on the reduction of cytochromes b and c 1 by succinate or 
ubiquinol which were identical to those caused by removal of the iron-sulfer protein from 
ubiquinol-cytochrome c reductase. Also, it inhibited the reduction of iron-sulfer protein 
and shifts the gx resonance of the EPRspectrum of the iron-sulfer protein from 1.79 to 
1.76. Therefore it was suggested that myxothiazol induces a conformational change in 
cytochrome b that is transmitted to a quinone binding site, which consists of peptide 
domains from both cytochrome b and iron-sulfur protein (69). 
Oo Myxothiazol / 
Q 
1--i~ bl 
Q Q~ I 
Fig. 9. Linear Arrangement of the Two b Hemes in Ubiquinol-Cytochrome 
c Reductase 
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5-Undecyl-6-hydroxy-4.7-dioxobenzothiazole (UHDBT) 
UHDBT was first intrduced by Folkers et al (70) as an inhibitor of mitochodrial 
respiration and identified as an inhibitor of electron transfer in be 1 segment of mammalian 
mitochondria by Trumpower and Haggerty(71). Addition ofUHDBT to ubiquinol-
cytochrome c reductase inhibits the oxidant induced reduction of cytochrome b (89). 
UHDBT increases the midpoint redox potential of the Rieske iron-sulfur protein from 
+280 to +350 mV at pH 7.2 and alters its EPR characterestics. An upfield shift of gz 
(1.80 to 1.76) and a downfield shift of gx (2.02 to 2.03) were observed (36). Since 
UHDBT raises the midpoint redox potential of iron-sulfur protein to at least +350 mV, that 
is much higher than the potential of cytochrome c1 (+225-+245 mV), therefore it was 
proposed that UHDBT inhibits the electron transfer in ubiquinol-cytochrome c reductase 
by its binding to iron-sulfur protein (36). It inhibits the oxidation of the reduced iron-
sulfur protein by ferricytochrome c 1, but not the reduction of the oxidized iron-sulfur 
protein by ubiquinone (36). 
Ubiquinone-binding Proteins 
Because of the uneven distribution of ubiquinone among the four complexes, the 
implication of specific Q-protein interaction in the mitochondrial electron-transfer chain 
appeared as early as the begining of 1960, when the electron transfer chain was resolved 
into four complexes. However, the existance of an ubiquinone-proein complex as the 
active entity in electron transfer chain was not advanced until1981 (44). The first 
evidence of the existance of specific ubiquinone-binding proteins in ubiquinol-cytochrome 
c reductase was deduced from the repeated observation of a 1: 1 stoichiometry between 
ubiquinone and cytochrome c1 in fully active isolated succinate-cytochrome c reductase 
( 117). When the concentration of Q is lower than that of cytochrome c 1, a stimulation of 
the activity of succinate-cytochrome c reductase was observed upon the addition of 
exogenous Q (86). If Q were merely dissolved in the phospholipid phase of succinate-
cytochrome c reductase, a fixed stoichiometry between ubiquinone and cytochrome c 1 
would not be expected. The introduction of the "proton motive Q cycle" mechanism of 
electron transfer in ubiquinol-cytochrome c reductase (42) and the acceptance of the 
chemiosmotic theory (1) of energy coupling have given further support to the idea of the 
existance of Q-binding proteins in ubiquinol-cytochrome c reductase. 
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A significant advance in the study of Q-binding proteins in ubiquinol-cytochrome c 
reductase was the detection of ubisemiquinone radical ( 62, 88). The concentration of the 
ubisemiquinone radical as high as 60% of the total Q present in ubiquinol-cytochrome c 
reductase has been detected at pH 9.0. The formation of the ubisemiquinone radical in 
ubiquinol-cytochrome c reductase was attributed to the presence of a Q-binding protein 
because: (1), in the free state or in phospholipid micells, ubisemiquinone radical is very 
unstable. It will undergo dismutation immediately and one would not expect to detect it at 
neutral or slightly alkaline conditions. (2), digestion of the ubiquinol-cytochrome c 
reductase with ,trypsin abolished the formation of the ubisemiquinone radical. 
Direct evidence of the existance ·of Q-binding proteins in ubiquinol-cytochrome c 
reductase came from an experiment on the interaction of arylazido ubiquinone, 2,3-
dimethoxy-5-methyl-6- { 10'-[ 4-(azido-2-nitroanilino-propionoxy)]-decyl} -1,4-
benzoquinone (QoCw NAPA), with mitochondrial ubiquinol-cytochrome c reductase, 
where two polypeptides with Mr=37 ,000 and 17,000 were photolabeled by arylazido 
ubiquinone (61). However the photoaffmity group is on the isoprenyl side chain, and the 
ability of Q-binding proteins to stablize the ubisemiquinone radical indicate that the binding 
of Q to protein may be involved more with the benzoquinone ring rather than the isoprenyl 
side chain. Therefore, the Q-binding proteins need to be further elucidated. 
The introduction of the concept of Q-binding protein into electron transfer 
complexes has changed the conventional t:ijinking about Q as a free molecule participating 
in electron transfer to the theory that Q functions as a Q-protein complex. Its function 
depends on both Q and Q-binding protein. The actual functional entity of Q is the Q-
protein complex, rather than Q alone. Therefore, elucidation of electron transfer and 
energy coupling mechanisms requires an understanding of the function of Q-binding 
proteins, the Q-protein interaction and the interaction between unbound Q and Q-protein 
complexes. 
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CHAPTER II 
INTERACfiON AND IDENTIFICATION OF UBIQUINONE-
BINDING PROTEINS IN UBIQUINOL-CYTOCHRO:ME c 
REDUCf ASE BY AZIDO-UBIQUINONE DERIVATIVES 
The existence of specific ubiquinone (Q)-binding proteins in the mitochondrial and 
photosynthetic electron transfer complexes has been established through biochemical 
studies (44). The Q-binding proteins in the mitochondrial cytochrome bq region have 
been detected by EPR measurement, using the ability to stablize ubisemiquinone radicals 
(88, 62). Recently, a photoaffmity labeling study using an arylazido-Q derivative has 
identified two polypeptides, with Mr=37 ,000 and 17,000 (61), in the highly purified 
ubiquinol-cytochrome c reductase, that are photolabeled by the reagent. Whether both 
proteins have individual Q-binding sites or both form a common Q-binding site remains to 
be elucidated. Evidence for the existence of two distict Q-binding sites in the cytochrome 
be 1 region is available (87, 92). 
One ambiguity of studies using an arylazido-Q derivative to identify the Q-binding 
protein is due to the location of the photoactivatable group on the Q ~olecule. In the 
arylazido-Q molecule, the photoactivable group is located on the part of the Q molecule 
where structural requirements for the electron transfer reaction are much less specific 
(157). A nonspecific labeling of complex III (161) with arylazido-phospholipid has been 
reported (93). This problem can now be resolved through the use of azido-Q derivatives. 
Among various azido-Q derivatives (94) synthesized for this work, 3-azido-2-methyl-5-
methoxy-6-geranyl-1,4-benzoquinone (3-azido-2-methyl-5-methoxy-Q2) and its 
hydrogenated derivative, 3-azido-2-methyl-5-methoxy-6-(3',7'-dimethyloctyl)-1,4-
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benzoquinone (3-azido-2-methyl-5-methoxy-Qzs) possess the best properties for use as 
photoaffinity labels in identification of those Q-binding protein(s) for which no isolation 
procedure has yet been developed, and for study of the interaction between Q and protein 
and/or between Q and phospholipids. These azido-Q derivatives have the ability to restore 
partial (12%) succinate-cytochrome c reductase activity to the Q- and PL-depleted 
succinate-cytochrome c reductase in the absent of light, and show complete binding to the 
Q-binding sites after photolysis (95). The relative ease of preparation of these azido-Q 
derivatives in radioactive form greatly aided our use of these azido-Q derivatives to 
unambiguously identify the Q-binding proteins in this segment of the electron transfer 
chain. 
Here we report the detailed photoaffmity labeling conditions, identification of the 
Q-binding proteins in the cytochrome bc1 region, and the effect of phospholipids and 
inhibitors on the Q-binding and Q:protein interaction. 
Experimental Procedures 
Beef heart submitochondrial particles (107), succinate-Q reductase (107), and a 
highly purified ubiquinol-cytochrome c reductase (96) were prepared and assayed 
according to reported methods. The Q- and PL-depleted ubiquinol-cytochrome c reductase 
was prepared by repeated ammonium sulfate precipitation in the presence of sodium 
cholate and glycerol ( 137). The depleted enzyme was dissolved in 50 mM phosphate 
buffer, pH 7.4, containing 10% glycerol and 1mM EDTA. Determination of protein 
concentration (98) was carried out according to the reported methods. Synthesis of 
oxidized and reduced form ofQo(CH2)JoBr and Q2 and their quantitative analysis were 
carried out according to the method developed in Dr. Yu's laboratory (106). 
Cholate, deoxycholate, antimycin A, and n-heptyl-4-hydroxyquinoline-N-oxide 
(HQNO) were purchased from Sigma. N,N'-Diallyltartardiamide (DATA) was obtained 
from Kodak and Insta-Gel from United Technologies Packard. 5-n-undecyl-6-hydroxy-
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4,7-dioxobenzothiazole (UHDBT) was obtained from Dr. B. L. Trumpower, Dartmouth 
Medical School. Other chemicals were obtained commercially at the highest purity 
available. 
Photolysis 
The Q- and PL-depleted ubiquinol-cytochrome c reductase was diluted with 50 
mM phosphate buffer, pH 7.4, containing 0.25% sodium cholate and 1 mM EDTA to a 
protein concetration of about 3 mglml. 3-Azido-2-methyl-5-methoxy-Q2s in 95% ethanol 
was added. The final concentration of ethanol in the mixture was kept lower than 5% to 
prevent denaturation of the enzyme. The azido Q-treated sample was incubated at 0°C for 
20 min in the dark then illuminated as in the previous work (61). For activity assay, the 
photolyzed samples were reconstituted with phospholipid and incubated at 0°C for 1 h 
prior to activity determination. The time course study of the incorporation of radioactivity 
of azido-Q into protein was conducted as reported (61). 
Determination of the Distribution of 3H-Radioactivity amon~ 
the Subunits of Ubiquinol-cytochrome c Reductase 
The photolyzed samples were diluted with 50 mM phosphate buffer, pH 7.4, to 10 
ml and centrifuged at 120,000 x g for 5 h .. The precipitates were collected and 
resuspended with 0.8 ml of water. The free Q, or the residual phospholipid-bound Q, 
was extracted from the protein by the method of Bligh and Dyer (99). The protein 
solution (0.8 ml) was mixed with 2 ml of methanol and 1 ml of chloroform, and incubated 
at room temperature for 30 min with occasional shaking. Mter incubation, 1 ml of H20 
and 1 ml of chloroform were added and the mixture was kept at room temperature for 
another 10 min with occasional shaking. The chloroform layer was separated from the 
aqueous layer by centrifugation and removed. The aqueous layer was extracted once more 
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with 1 m1 of chloroform and the chloroform layer was removed. The methanol in the 
aqueous layer was evaporated under a stream of nitrogen gas before the solution, which 
contains the photolyzed protein, was subjected to lyophilization. the lyophilized sample 
was suspended in 0.2 m1 of 20 mM K2HP04 and shaken gently at room temperature for 
two h. SDS (5 mg/mg protein) and B-mercaptoethanol (1%) were added and the protein 
was incubated at 37 oc for 2 h before it was subjected to SDS-PAGE. The SDS-
polyacrylamide gel columns were prepared either by the method of Weber and Osborn 
(121) or by the modified method substituting the cross-linker bisacrylamide, in the Weber 
and Osborn system, with a cleavable cross-linker, N,N'-diallytartardiamide (DATA) (100, 
101 ). The buffer used for gel column and electrophoresis was 0.1 M N a/N a phosphate 
bufer, pH 7 .0. Electrophoresis was performed at 8 rnA for each gel column. Each gel was 
loaded about 30 ~g of protein. After electrophoresis, the gels were stained and destained 
according to the reported method (121). The gels were sliced according to the stained 
protein bands. About three gels were used for each sample. When the Weber and Osborn 
gel system was used, the gel slices were hydrolyzed with 6 N NH40H according to the 
method described previously (61). When the SDS-DATA gel system was used, the gel 
slices were completely dissolved by incubation in 0.7 ml of 3% periodic acid at room 
temperature for 1 h. 10 m1 of lnsta-Gel counting fluid was added and radiactivity 
determined 
Results and Discussion 
Biological Properties of 3-Azido-2-methyl-5-methoxy-6-
(3'. 7' -dimethyloctyl)-1.4-benzoquinone (3-azido-2-
methyl-5-methoxy-Q2sl 
Preliminary studies showed that the azido-Q derivatives synthesized in Dr Yu's 
laboratory all partially restorate the enzymatic activity of Q- and PL-depleted succinate-
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cytochrome c reductase in the dark and all abolish the restored activity upon photolysis. 3-
Azido-2-methyl-5-methoxy-Q2 is superior to the other azido-Q derivatives for study of the 
Q:protein interaction and identification of the Q-binding proteins because of its ability to 
completely inactivate the photolyzed samples against reactivation by other active Q-
derivatives. This azido-Q derivative was made into 14c- or 3H-radioactive form through 
methylation and used in the early stage of this investigation. Although 3-azido-Q2 has 
properties similar to that of 3-azido-2-methyl-5-methoxy-Q2, the poor yield in the 
synthesis made subsequent preparation of the radioactive form difficult~ It was further 
observed that hydrogenation of the geranyl group of 3-azido-2-methyl-5-methoxy-Q2 to 3-
azido-2-methyl-5-methoxy-6-(3', 7'-dimethyloctyl)-1,4-benzoquinone (3-azido-2-methyl-
5-methoxy-Q2s) did not alter the biological properties, compared to the unhydrogenated 
parent compound. Table III compares the biological activities of 3-azido-2-methyl-5-
methoxy-Q2 and 3-azido-2-methy-5-methoxy-Q2s· When these two azido-Q derivatives 
were added to the Q- and PL-depleted ubiquinol-cytochrome c reductase in the absence of 
light, both derivatives restored about 12% of the reconstitutive activity to the depleted 
enzyme (relative to that restored by QoCwBr which restored over 90% of the activity of 
undepleted reductase). These azido-Q derivatives had no effect on the ubiquinol-
cytochrome c reductase activity without photolysis when reduced QoCwBr or Q2 was 
used as substrate. The reconstituted activity is the ability of ubiquinol-cytochrome c 
reductase to reconstitute with succinate-Q reductase to form succinate-cytochrome c 
reductase. The reconstitution was routinely performed by addition of Q analogues to the 
Q- and PL-depleted ubiquinol-cytochrome c reductase followed by addition of 
phospholipid and excess succinate-Q reductase. The ubiquinol-cytochrome c reductase 
activity of the preparation was measured in the presence of 50 J.!M reduced form of Q2 
(Q2H2). Since Q2H2 is the substrate for the ubiquinol-cytochrome c reductase assay, no 
difference in ubiquinol-cytochrome c reductase was observed when the Q- and PL-
depleted ubiquinol-cytochrome c reductase was treated , in the absence of light, either with 
Q 
TABLE ID 
BIOLOGICAL ACITVITY 3-AZID0-2-MElHYL-5-METIIOXY-(h 
AND 3-AZID0-2-ME'IHYL-5-METIIOXY -Q2s 
Enzymatic activitiee 
derivative~~ 
Succinate-cytochrome c 
(reconstituted) Ubiquinol-cytochrome c 
Before h• · After h• Inactivation Before h• After h• Inactivation 
,.mole % ,.mole reduced/min-Trill reduced/min· Trill 
None 0.96 0.89 7.3 87.2 81.7 
QoC10Br 
3-Azido-2-methyl-5-methoxy-Q2 
3-Azido-2-methyl-5-methoxy-Q:z. 
17.51 
3.05 
3.10 
16.28 
0.61 
0.58 
7.1 87.5 81.4 
80.0 87.1 5.2 
81.3 87.0 5.2 
Two-tenth-ml aliquots of the Q- and PL-depleted ubiquinol-cytochrome c reductase in 50 mM phosphate buffer, 
pH 7.4, containing 0.25% sodium cholate and 1 mM EDTA were mixed with 5 ~o~l of 5 mM alcoholic solution of Q 
analogues and incubated at 0 ·c for 10 min in the dark. Fifty-~o~l aliquots were withdrawn and mixed with 5 ~o~l of 
asolectin micellar solution (10 mg/ml in H20) and reconstituted with 80 ~o~l of succinate-Q reductase (3 mg/ml) in 
20 mM Tris-succinate, pH 8.0, containing 0.1% deoxycholate to form succinate-cytochrome c reductase. After 1 h 
incubation, the mixture was diluted with 50 mM phosphate buffer, pH 7.4, containing 0.5% sodium cholate and 
the succinate-cytochrome c and ubiquinol-cytochrome c reductase activities were assayed. The remaining enzyme-
Q mixture were subjected to photolysis at 0 ·c for 20 min. After photolysis, aliquotll were withdrawn and 
reconstituted with asolectin and auccinate-Q reductase and the activities of both reductase& were all88yed. ~uced 
Q2, 50 ~o~M, was used as substrate for the ubiquinol-cytochrome c reductase activity 88118y. 
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a Q-derivative or azido-Q derivative followed by addition of phospholipid. Addition of 
only phospholipids to the Q- and PL-depleted ubiquinol-cytochrome c reductase also 
showed the same ubiquinol-cytochrome c reductase activity. However, photolysis of 
these azido-Q treated-enzyme complexes completely abolished, not only the reconstitutive 
activity, but also the ubiquinol-cytochrome c reductase activity. These results suggest that 
the low reconstituted activity obtained by addition of these two azido-Q derivatives to the 
Q- and PL-depleted ubiquinol-cytochrome c reductase is a result of the low electron 
transfer ability of these azido-Q derivatives, and not of incomplete binding of the Q-
binding sites by these azido-Q derivatives. 
The complete inactivation of the ubiquinol-cytochrome c reductase activity upon 
photolysis of this azido-Q derivative treated samples indicates that all the binding sites 
were covalently linked to the azido-Q derivatives, preventing access of Q2H2. Thus the 
degree of azido-Q binding could be directly indicated by assaying the QH2-cytochrome c 
reductase activity after photolysis. 
Illumination Time-dependent azido-0 Uptake by 
Protein and Loss of Enzymatic Activity 
Fig. 10 shows the photolysis time-dependent binding of the radioactive [3H]azido-
Q derivative to the ubiquinol-cytochrome c reductase protein and inactivation of the azido-
Q-treated ubiquinol-cytochrome c reductase. When the azido-Q-treated and PL-depleted 
ubiquinol-cytochrome c reductase was subjected to varying times of photolysis at 0-2 °C 
with long wavelength UV light, the ubiquinol-cytochrome c reductase activity, measured 
after reconstitution with phospholipid, decreased concurrently with increased [3H]azido-Q 
derivative uptake by protein over time. The maximal inactivation was observed when the 
azido-Q-treated sample was illuminated for 20 min. lllumination beyond 20 min did not 
further inhibit the activity, although the azido-Q uptake by the enzyme complex continued 
to increase, at a slower rate. A control sample, treated with the same amounts of solvent 
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Fig. 10. Effect of lliumination Time on the Binding of Azido-Q Derivative to 
Ubiquinol-Cytochrorne c Reductase and on Activity Inhibition. 
Five ~1 of 95% ethanol or of [3H]3-azido-2-rnethyl-5-rnethoxy-
Q2s (13.4 rnM in 95% ethanol, specific radioactivity 500 
cpm/nmol) were diluted with 0.2 ml of 50 m.M phosphate 
buffer, pH 7 .4, containing 0.25% sodium cholate and 1 rnM 
EDTA in the dark, then mixed with 50 ~1 of the Q- and PL-
depleted ubiquinol-cytochrome c reductase (12 mg/ml, 120 J.1M 
cytochrome b) in 50 niM phosphate buffer, pH 7.4, containing 
10% glycerol and 1 rnM EDT A. Photolysis was carried out 
under the conditions described under " Experimental 
Procedures." At the times indicated, 1 0-~ aliquots were 
withdrawn and mixed with 50 ~1 of 50 mM phosphate buffer, 
pH 7.4, containing 0.5% sodium cholate, 20% glycerol, and 
0,05 mg of asolectin micellar solution. Ubiquinol-cytochrome c 
reductase activity of the control (~) and the azido-Q treated (0) 
samples were assayed after incubation at 0 ·c for 1 h. Ten-~ 
aliquots were also withdrawn from the azido-Q-treated sample at 
the given time intetvals for the determination of radioactivity 
incorporation (x). 
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but no azido-Q, was placed beside the azido-Q-treated sample during photolysis. Little 
loss of activity occurred in the illuminated control sample. A plot of the logarithm of 
inactivation versus illumination time (not shown) yields a nearly linear curve, indicating 
that the inactivation resulting from photolysis follows first order kinetics. The kinetics of 
azido-Q uptake by ubiquinol-cytochrome c reductase, however, was more complex, as 
two different rates were involved, one of which was 10 times faster than the other. The 
rapid uptake seemed to correlate with the inactivation and was complete in 20 min of 
photolysis. The slower uptake was probably due to nonspecific binding of azido-Q 
derivative to protein. Thus, a 20-min illumination time was chosen for the identification of 
the Q-binding protein and study of the Q:protein interaction.in ubiquinol-cytochrome c 
reductase. The kinetics of azido-Q uptake by protein and inactivation are quite similar to 
those observed with the arylazido-Q derivative (61), although the inactivation was more 
complete with the azido-Q derivative. 
Identification of the 0-binding Protein(s) in 
Ubiquinol-Cytochrome c Reductase 
Since the uptake of azido-Q derivative by ubiquinol-cytochrome c reductase upon 
photolysis was correlated with the enzymatic inactivation, it is reasonable to assume that 
the azido-Q derivative is bound specifically to the Q-binding site(s). Thus, the distribution 
of the covalently bound azido-Q among the subunits of ubiquinol-cytochrome c reductase 
after SDS-PAGE indicates the specific Q-binding protein in this enzyme complex. Fig.ll 
shows the 3H-radioactivity distribution among subunits of ubiquinol-cytochrome c 
reductase under various conditions. Two SDS-polyacrylamide gel system were used: 
System A, the Weber-Osborn gel system, exactly as described for identification of the Q-
binding protein in ubiquinol-cytochrome c reductase with the arylazido-Q derivative 
(QoCwNAPA) (61); and System B, the SDS-DATA gel system, which is a modification 
of the Weber-Osborn gel system. The Weber-Osborn cross-linker, bisacrylamide, was 
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replaced with a cleavable linker, N,N'-diallytartardiamide (DATA) (101). The advantage 
of using the SDS-DATA gel system is that the gel slices can be completely dissolved in 
2% periodic acid and used for radioactivity determination without further treatment. The 
SDS-DATA gel system has been successfully used for identification of the Q-binding 
protein in a bacterial reaction center (100). As shown in Fig 11, the electrophoretic pattern 
of ubiquinol-cytochrome c reductase obtained from the SDS-DA TA gel system was similar 
to that obtained from the Weber-Osborn gel system, with seven major protein bands 
observed in each. Although the electrophoretic mobility of each subunit, relative to 
cytochrome c in the SDS-DA TA gel system was different from that in the Weber-Osborn 
gel system, the distribution of radioactivity among the subunits of ubiquinol-cytochrome c 
reductase was the same in those two gel systems (see panels i and ii of Fig. 11, A and B). 
One can assume that the protein subunits of ubiquinol-cytochrome c reductase shown in 
the SDS-DATA gel correspond to those observed in the Weber-Osborn gel system. The 
former is preferred for study of the Q-binding proteins in ubiquinol-cytochrome c 
reductase. 
Results of photoaffinity labeling experiments are often complicated by the 
radioactivity observed near the dye front of the gel column resulting from free Q, 
phospholipid-Q, or detergent-Q adducts. It is especially important that the electrophoresis 
data be completely devoid of this radioactivity interference when the Q-binding site is in a 
small molecular weight protein. In the previous study of interaction of an arylazido-Q 
derivative with ubiquinol-cytochrome c reductase (61), it was observed that the 
radioactivity interference resulting from free Q and PL-bound Q in the gel column can be 
removed by prolonged destaining of the gel in the acetic acid-methanol solution. However, 
this usually required more than two weeks, with constant changes of destaining solution, 
to completely eliminate the interference. Introduction of an organic solvent extraction step 
successfully eliminated this interference. Fig. 11 shows the distribution patterns of 
radioactivity after (i) and before (ii) the extraction step and in the extract (iii) in SDS-
bisacrylamide and SDS-DATA gel systems. 
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To ensure that the organic solvent extraction of the photolyzed sample removed no 
protein-Q complex but only free Q, Q-PL, or Q-detergent adducts, the chloroform extract 
of the photolyzed samples were collected, dried, redissolved in a small amount of alcohol 
and assayed for protein. When the alcohol solution was mixed with the untreated, 
depleted ubiquinol-cytochrome c reductase and subjected to SDS-PAGE, the radioactivity 
was found mainly on the dye front of the gel column (see panel iii of Fig. 11, A and B). 
The very low amount of radioactivity found with the protein confirmed that all the 
[3H]azido-Q in the chloroform extract had been photoactivated and covalently linked to 
some small molecules in the system and was no longer able to react with protein. This 
result also indirectly substantiated the observation that the radioactivity located in the 
protein bands of panel i and ii resulted from the covalent linkage between azido-Q and 
protein subunits and not a nonspecific hydrophobic interaction between photolyzed Q 
molecule and protein during SDS-PAGE. It should be mentioned that the extraction 
method described under" Experimental Procedure" for the removal of the non-protein 
bound azido-Q derivative does not cause protein aggregation, a common phenomenon 
after organic solvent extraction, as no protein remained on the top of the gel column after 
SDS-PAGE. 
Panels i and ii of Fig. 11 clearly show that the two proteins with Mr=37 ,000 and 
17,000 are responsible for specific Q-binding in ubiquinol-cytochrome c reductase. These 
results are identical to those obtained from a previous study in this laboratory, using the 
arylazido-Q derivative, QoCwNAPA, as the labeling reagent. In addition to the 
Mr=17,000 and 37,000 subunits, a significant amount of radioactivity was also found in 
the Mr=30,000 protein, which was not labeled when QoCwNAPA was used. Whether 
the observed radioactivity on the Mr=30,000 subunit resulted from an abnormal 
electrophoretic mobility of the Mr=37 ,000 protein or from an actual partial labeling of the 
Fig. 11. Effect of Organic Extraction of the Azido-Q Derivative Treated Sample 
on the Radioactivity Distribution among the Subunits of Ubiquinol-
Cytochrome c Reductase in the Weber-Osborn Gel and the SDS- · 
PAGE Gel Systems. Four-tenth ml of the Q- and PL-depleted 
ubiquinol-cytochrome c reductase (3.1 mg/ml) was treated with 10 
Jll of 6.3 mM ethanolic solution of [3H]3-azido-2-methyl-5-
methoxy-Q2s (4000 cpm/nmol). The mixture was photolyzed and 
diluted to 10 ml with 50 mM phosphate buffer, pH 7.4. The 
protein was collected by centrifugation and suspended with 0.5 ml 
of H20. The sample was used for the SDS-PAGE with or without 
subject to organic solvent extraction step according to the procedure 
described under "Experimental Procedures," using Weber-Osborn 
gel (A) and SDS-DATA gel (B) systems. Panels i and ii represent 
sample with and without organic solvent extraction, respectively, 
and panel iii represent a mixture of untreated ubiquinol-cytochrome 
c reductase and the organic extract of azido-Q-treated sample. 
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Mr=30,000 protein remains to be verified experimentally. The electrophoretic abnormality 
of the Mr=37 ,000 protein in ubiquinol-cytochrome c reductase has been documented 
(44,102). In fact, in some reports, the Mr=37,000 subunit was completely absent from 
the subunit structure of ubiquinol-cytochrome c reductase or complex III on SDS-PAGE. 
The Mr=37 ,000 subunit of ubiquinol-cytochrome c reductase has been purified and 
identified as one of the b cytochrome proteins (82). The Mr=17,000 protein has been 
identified as another b cytochrome protein (82). The Mr=l7,000 protein has an 
electromobility faster than the Rieske iron-sulfur protein but slower than the cytochrome 
q -associated protein in the SDS-PAGE. It is not the same protein recently isolated and 
assumed by Wang and King to be QPc (103). The protein they assumed to be the Q-
binding protein in the cytochrome b-e 1 region has the same electrophoretic mobility as the 
cytochrome c1 associated small molecular weight polypeptide (Mr=15,000 or less), and 
was not labeled either with the radioactive azido-Q or arylazido-Q derivative. The nature 
of this protein (103) remains unclear, but is likely to be a Q:PL:protein mixture rather than 
a specific Q-binding protein. 
Effect of the Redox State of the Azido-0 Derivative on 
the Binding to Ubiquinol-Cytochrome c Reductase 
It has been suggested that the binding affinity of reduced Q to ubiquinol-
cytochrome c reductase is stronger than that of the oxidized form of Q (85). It is, 
therefore, of interest to see whether the reduced azido-Q derivative binds ubiquinol-
cytochrome c reductase better than does the oxidized azido-Q derivative. When the 
depleted ubiquinol-cytochrome c reductase was treated with different redox forms of 
azido-Q derivative at various concentrations, a 50% inactivation after photolysis was 
observed when 2 mol of azido-Q/mol of cytochrome b in the depleted enzyme complex 
were used, regardless of the redox state of the azido-Q derivative (see Fig. 12). The 
maximal inactivation by either redox state of the azido-Q derivative was almost the same. 
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Fig. 12. Effect of the Redox State of the Azido-Q Derivative on the 
Binding to Ubiquinol-Cytochrome c Reductase. Indicated 
. amounts of 3-azido-2-methyl-5-methoxy-Q2s in 0.2 ml of 
50 mM phosphate buffer, pH 7 .4, containing 0.25% 
cholate and 1 tru4 EDTA were reduced by 0.43 M 
succinate, in the presence of succinate-Q reductase ( 10 ~. 
1.6 mg/ml) in the dark at room temperanrre. Mter 
reduction, the activity of succinate dehydrogenase was 
inhibited by the addition of oxalacetate (5J.1l, 1.6 mglml) 
and the mixture were placed in the ice bath and mixed with 
60 Jll of Q- and PL-depleted ubiquinol-C)1ochrome c 
reductase (0). When the oxidized azido-Q (x) was used, 
0.2-ml aliquots of buffer containing the indicated amount 
of azido-Q were mixed with the depleted enzyme complex 
without pretreatment. Ten-~ aliquota were withdrawn 
from each sample before and after photolysis, 
reconstitution with asolectin, and assayed for ubiquinol-
cytochrome c reductase activity. The per cent activity 
remaining after photolysis was based on the activity 
obtained before photolysis of each sample. 
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The results indicate that no significant difference in the Q-binding affinity between the 
oxidized and reduced forms of azido-Q exists in the cytochrome b-e 1 region of the electron 
transfer chain. 
In the above experiment, the reduced form of the azido-Q derivative was generated 
by reduction of the oxidized azido-Q derivative with a catalytic amount of succinate-Q 
reductase and succinate. The formation of the reduced azido-Q was confirmed by thin 
layer chromatography after extraction of the azido-Q from the system. Mter the reduction 
was complete, the enzymatic activity of succinate-Q reductase was stopped by the addition 
of oxalacetate before mixing with depleted ubiquinol-cytochrome c reductase, to prevent a 
slow reduction of the depleted enzyme by the added succinate-Q reductase. To control for 
possible complications resulting from the addition of succinate and oxalacetate to the 
system, succinate and oxalacetate were also added to the system with oxidized azido-Q 
derivative. No difference in the inactivation effect of the oxidized azido-Q derivative after 
photolysis was found between the system~ with and without succinate and oxalacetate. 
Since more than one specific Q-biljlding subunit was detected in ubiquinol-
cytochrome c reductase by the azido-Q derivative, the observed equal degree of 
inactivation by the oxidized and reduced forms of the azido-Q derivative after photolysis 
might result from the different contributions of the Q-binding proteins to the azido-Q 
binding. To clarify this point, the radioactivity distribution among subunits of the enzyme 
complex treated with oxidized and reduced forms of the azido-Q derivative was 
investigated, and the results were compared. An identical distribution of 3H-radioactivity 
among the subunits of ubiquinol-cytochrome c reductase was obtained for the reduced and 
oxdized azido-Q derivative treated samples. 
Effect of Phospholipids on the Inactivation of Ubiquinol-
Cytochrome c Reductase by Azido-0 Derivative 
after Photolysis 
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The requirement for phospholipids, in addition to Q, for restoration of enzymatic 
activity and stabilization of the ubisemiquinone radical (44, 88) in ubiquinol-cytochrome c 
reductase, suggests an intimate relationship between the phospholipids and Q in this 
segment of the electron transfer chain. The reported observation (117) that only by adding 
Q prior to addition of phospholipids to the Q- and PL-depleted succinate-cytochrome c 
reductase can the enzymatic activity be completely restored, further comfrrms the role of 
phospholipids in the Q:protein interaction. A similar phospholipid effect was observed 
with azido-Q derivative binding to ubiquinol-cytochrome c reductase. As indicated in 
Table IV, when the azido-Q derivative was added to the Q- and PL-depleted ubiquinol-
cytochrome c reductase prior to the addition of phospholipids, a greater inactivation after 
photolysis was observed than in the sample mixed with phospholipids before addition of 
azido-Q derivative. This result suggests that at least one of the Q-binding sites can be 
easily masked or modified by phospholipids when Q is absent. It is possible that when 
photolysis of the azido-Q-treated enzyme complex is carried out in the presence of 
phospholipids, some of the photoproduced nitrenes may covalently link to phospholipids 
close to the Q-binding site, resulting in less inactivation of the ubiquinol-cytochrome c 
reductase. ·When phospholipids and azido-Q were premixed and then added to the 
depleted enzyme, only slightly less inactivation was observed after photolysis than with 
addition of azido-Q prior to phospholipids. This suggests that the binding of azido-Q to 
the Q-binding site is some what stronger than the binding of phospholipids to the Q-
binding site. These results differ from those obtained by activity restoration using Q6 
mixed first with phospholipids, and then added to the depleted enzyme complex (117). In 
this case, only 30% of the activity was restored when Q6 and phospholipids were mixed 
before being added to the depleted enzyme, compared to the activity restored by addition 
TABLE IV 
EFFECf OF ADDffiON SEQUENCE OF PHOSPHOLIPIDS 
AND AZIDO-Q TO 1HE DEPLETED UBIQUINOL-
CYTOCHROME c REDUCfASE (dQCR) ON 
1HE AZIDO-Q BINDING AFFINITY 
.. 
Treatmenta 
1. dQCR + azido-Q . 
.2. dQCR + azido-Q + PL 
3. dQCR + PL + azido-Q 
4. dQCR + (PL + azido-Q) 
Ubiquinol-cYtbchrome c ~uctue 
Before h• After b. luactivation 
• pmol c 
reduced/min."" 
91.5 11.9 
92.3 24.0 
92.2 51.6 
92.2 29.5 
0.23-mlallquots of the depleted ubiquinol-cytochrome..c reductase, 
1.1~ .mg/inl, i11 50 JDM.phosphate buffe~;pH 7.~. containing 0.25%. 
sodium· chola~e and 1 mM EDTA were mixed with i) 4 p.l of 3-azido-· 
2-methyl-5-niethoxy-~ (6.2 mM); 2) 4 p.l of 3-azido-2-methyl-5-
methoxy-~; 3) 25 p.l of asolectin micellar solution (10 mg/ml in 
H20); and ~) 29 p.l. of a miXture of 3-azido-~-methyl-5-.methoxy-~ 
and asolectin (0.85 mM azido-Q and 86 mg/ml Qf asolectin)~ After 
incubation at 0 ·c foi 20 min in the dark, 25 p.l of asolectin solution 
was added to 2, and 4 p.l of 3-azido-2-methyl-5-methoxy-~ was 
added to 3, and the samples were incubated in the dark for another 
20.min. After incubation, a 0.1-ml aliquot was withdrawn from each 
sample and diluted with 0.5 ml of 50 mM phosphate buffer, pH 7.4, 
containing 0.5% sodium cholate and 10% glycerol for activity mea-
surement. Sample 1 was diluted in the same buffer, but containing 
0.11 mg of asolectin. The rest of the solutions .. were subjected to 
photolysis for 20 min at 0 ·c. After photolysis, aliquots were with-
drawn, diluted exac.tly. ai were those withdrawn before phot.olysis, · 
.. . anp.ubiqtiinol~c~hrome c reductase activity was ~assayeli 
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of Q6 prior to the addition of phosphlipids. One explanation for this difference is that the 
photoaffinity labeled Q, once activated by photolysis, becomes covalently linked to the Q-
binding protein and can not be displaced by the competing phospholipids. Thus the 
binding competition during photolysis favors azido-Q against phospholipids. 
The phospholipid masking or competition at the Q-binding site can be overcome by 
exess (substrate level) Q2H2 as the Q-depleted but phospholipid-sufficient enzyme 
showed full activity when assayed with Q2H2. 
Effect of Phospholipids on the Distribution of Azido-0 
Binding among Subunits of Ubiquinol-cytochrome 
c Reductase 
The Q- and PL-depleted ubiquinol-cytochrome c reductase was reconstituted with 
phospholipid in the absence of azido-Q derivative and subsequently replenished with the 
azido-Q derivative at various time intervals. The amount of azido-Q derivative binding to 
the Q-binding sites decreased, as indicated by the decreased inactivation upon photolysis. 
as the time of phospholipids incubation with the depleted enzyme increased (see Fig.13 
A). The decreased azido-Q derivative binding to the Q-binding site, or the decreased 
inactivation upon photolysis, resulting froin prolonged incubation of phospholipids with 
the depleted enzyme before addition of azido-Q, could be explained as either an increase in 
enzyme aggregation by phospholipids upon incubation or, more probably, a gradually 
increasing occupation (masking) of the Q-binding sites by phospholipids. This masking 
effect could also result from a protein conformational change upon incubation with 
phospholipids in the absence of Q, thus changing the affinity of Q-binding. The fact that 
the Q-depleted but PL-sufficient sample shows full ubiquinol-cytochrome c reductase 
activity when Q2H2 is used as substrate in the assay mixture, supports this deduction. 
As the amount of azido-Q added to the Q-depleted but PL-sufficient ubiquinol-cytochrome 
c reductase was increased, an increase in inactivation after photolysis was observed. This 
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Fig. 13. Effect of Phospholipid Incubation Time on the Inactivation of the 
Q- and PL-depleted Ubiquinol-Cytochrome c Reductase by 
Azido-Q derivatives after Photolysis. A, Five-tenth ml of the 
Q- and PL-depleted ubiquinol-cytochrome c reductase (8.5 
mglml) was treated with 100 J.Ll of asolecti.n micellar solution 
(10 mg/ml in H20) and incubated at 0 ·c. At the Times 
indicated, 45-J.Ll aliquots of the sample were withdrawn and 
mixed with 0.15 ml of 50 mM phosphate buffer, pH 7 .4, 
containing 0.25% sodium chelate, 1 mM EDTA and 0.2 mM 
3-azido-2-methyl-5-methoxy-Q2g. Ten Jll aliquots were 
withdrawn before and after photolysis, and assayed for 
ubiquinol-cytochrome c reductase activity. B, Two-tenth ml 
of the depleted reductase (87 J.LM cytochrome b) were mixed 
with 0.9 ml of 50 mM phosphate buffer, pH 7.4, containing 
0.25% sodium chelate, 1 mM EDT A, and 0.2 mM azido-Q 
derivative. After incubation at 0 ·c for 5 min, the mixture was 
mixed with 54 j..Ll of asolectin micellar solution (10 mglml in 
H20). At the times indicated, 0.2-ml aliquots were withdrawn, 
photolyzed, and assayed for activity. 
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also supports the observation that replenishing Q to the Q-depleted, PL-containing 
ubiquinol-cytochrome c reductase requires a higher concentration of Q than in the absence 
of phospholipids. 
When the azido-Q derivative was added to the Q- and PL-depleted ubiquinol-
cytochrome c reductase first, followed by phospholipids, the amount of inactivation after 
photolysis was nearly independent of the incubation time of phospholipids in the 
reconstituted system (see Fig 13 B). This suggests that once the azido-Q derivative is 
bound to the Q-binding site, it can not be removed or displaced by phospholipids, and, 
indirectly, suggests that phospholipids facilitate the Q-binding, as supported by the fact 
that stabilization of the ubisemiquinone radical is phospholipid-dependent (101). 
Since two subunits in ubiquinol-cytochrome c reductase were heavily labeled with 
[3H]azido-Q derivative upon photolysis, it is of interest to see whether the decreased 
azido-Q uptake by ubiquinol-cytochrome c reductase in the presence of phospholipids 
results from a decrease of the azido-Q binding by a specific Q-binding subunit or by both 
Q-binding subunits. Fig. 14 compares the 3H-radioactivity distribution patterns, after 
photolysis and SDS-PAGE, among subunits of the complex from samples treated with 
various phospholipid incubation times. When phospholipids were preincubated with the 
depleted enzyme complex for 0, 1, and 5 h before the addition of [3H]azido-Q derivative, 
the inactivation after photolysis was 83, 50, and 10%, respectively. The 3H-radioactivity 
incorporation at the Mr= 17,000 protein decreased as the inactivation after photolysis 
decreased. This result demonstrates that the Mr= 17,000 protein in ubiquinol-cytochrome c 
reductase is a Q-binding protein, with a Q-binding site easily masked by phospholipids in 
the absence ofQ. By contrast, the radioactivity incorporation at the Mr=37,000 or 30,000 
protein was relatvely constant with varying phospholipid incubation, indicating that this Q-
binding site is less affected by phospholipids. Although the incorporation of [3H]azido-Q 
derivative at the Mr=37 ,000 or 30,000 protein showed no correlation with the inactivation 
after photolysis, the constant incorporation of azido-Q into this protein makes it unlikely 
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Fig. 14. Effect of Phospholipid Incubation Time before Addition of Azido-Q Derivative on 
the Distribution of [3H]-radioactivity among Subunits of Ubiquinol-cytochrome 
c Reductase. The Experimental conditions were as described for Fig. 13A, 
except [3H]3-azido-2-methyl-5-methoxy-Q28 was used. A, Zero time 
incubation, 18% activity remained after photolysis; B, 1-h incubation, 50% 
activity remained after photolysis; and C, 5-h incubation, 90% activity remained 
after photolysis. The conditions for photolysis and preparation of samples for 
SDS-PAGE were as described for Fig. llB, panel i. 
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that this is a nonspecific uptake. It is not clear at present whether or not the covalently 
linked azido-Q molecule in the Q-binding site of the Mr=37 ,000 protein is still functionally 
active, that is , whether or not displacement or rotation of the Q molecule in this Q-binding 
site is required during the redox reaction. Although two different Q-binding sites in 
ubiquinol-cytochrome c reductase have been documented through inhibitor studies (92) 
further clarification of the Mr=37 ,000 protein as a Q-binding protein is needed. One 
possible approach to this problem is to identify the Q-binding site, particularly the amino 
acid residues involved at the Q-binding site. Investigation of this aspect is currently under 
way in Dr. Yu's laboratory. 
Effect of Inhibitors on the Binding of Azido-0 Derivative 
to Ubiguinol-cytochrome c Reductase 
The inhibitory effect of antimycin A and UHDBT on ubiquinol-cytochrome c 
reductase has been well established (104) both with intact enzyme complex and the Q- and 
PL-depleted form. The reversal of antimycin A (105) or UHDBT (69) inhibition by 
addition of Q derivarives has also been claimed or implied. It is, therefore, of interest to 
see whether the azido-Q derivative can reverse the inhibitory effect of antimycin A or 
especially, that ofUHDBT, which contains a quinone group and has been suggested to be 
a quinone analogue. Addition of the azido-Q derivative to the Q- and PL-depleted 
ubiquinol-cytochrome c reductase either before or after addition of antimycin A or 
UHDBT did not alter the inhibitory action of these compounds, compared to the enzyme 
samples to which no azido-Q derivative was added. The distribution of the 3H-
radoactivity among the subunits of the enzyme upon photolysis and SDS-PAGE was 
practically identical in the presence or absence of these inhibitors, indicating that the Q-
binding sites in ubiquinol-cytochrome c reductase are probably not the inhibitor binding 
site(s) of antimycin A or UHDBT, even though UHDBT has often been referred to as a Q 
analogue. The same results were obtained when the arylazido-Q derivative was the 
photoaffinity labeling reagent (61). 
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It is well established (104) that HQNO inhibits electron transfer in the cytochrome 
b-e 1 segment of the mitochondrial electron transfer chain by inhibiting the oxidation of 
ubiquinol. This inhibition can be reversed by addition of Q derivatives (1 05). Whether or 
not the binding site of HQNO is the same as the Q-binding site, however, is not 
established. The effect of Q on inhibition by HQNO must be studied in succinate-
cytochrome c reductase, intact or reconstituted, since HQNO is not inhibitory in the 
ubiquinol-cytochrome c reductase assay. Fig. 15 shows the concentration-dependent 
reversal of the HQNO inhibition by Q derivatives. When QoCwBr at a concentration of 3 
mol/mol cytochrome b, was added to the HQNO-treated succinate-cytochrome c reductase, 
87% of the original succinate-cytochrome c reductase activity was restored. When the 
azido-Q derivative, at 1.5 mol/mol cytochrome b, was added to the HQNO-treated sample, 
about 67% of the original succinate-cytochrome c reductase activity was restored. 
However, when duroquinol (2,3,5,6-tetramethyl-1,4-benzoquinone) was used, no 
restoration of the HQNO-inhibited activity was observed. In the absence of inhibitor, a 
I 
10-20% activation of intact reductase by addition of QoCwBr was observed. This is due 
to a partial deficiency of Q in the enzyme preparation resulting from the isolation 
procedure. The amount of QoCwBr required for this activation was very low: less than 1 
mol/mol cytochrome b. No detectable increase of activity in intact reductase was observed 
in samples treated with azido-Q derivative, even when high concentrations of azido-Q 
derivative were used. This is probably due to the low electron transfer efficiency of the 
azido-Q derivative. When the succinate-cytochrome c reductase samples which were 
inhibited by HQNO and reactivated by the azido-Q derivative were subjected to photolysis, 
no decrease of the succinate-cytochrome c reductase activity or ubiquinol-cytochrome c 
reductase activity was observed. These results can be explained in several ways: (a) the 
HQNO is probably not bound to the Q-binding site and the reversal of the HQNO 
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Fig. 15. Restoration of the HQNO-inhibited Activity by Q 
Derivatives. 4.2-ml aliquots of intact succinate-
cytochrome c reductase, 1.1 mg/ml ( 4.5 J.!M 
cytochrome b), in 50 mM phosphate buffer, pH 
7 .4, containing 0.4% sodium cholate and 3% 
ammonium sulfate were mixed with 21 Jll of 
95% ethanol (0,.::\, 0 ) or 21 Jll of 29.4 mM 
HQNO in 95% ethanol (e,.A, • ). Aliquots of 
0.2 ml were withdrawn from the control and 
HQNO-treated samples and mixed with 5 Jll of 
ethanolic solution containing the indicated 
concentration of QoC10Br (O,e), 3-azido-2-
methyl-5-methoxy-Q2s (.::\,.A), or duroquinol 
(D,.lAfter incubation in the dark for 20 min, 
the succinate-cytochrome c reductase activity was 
assayed. 
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inhibition by Q analogue does not involve direct displacement of HQNO from the Q-
binding site; (b) the binding ofHQNO to the Q-binding site is Q concentration-dependent 
and native Q binds better than does azido-Q derivative; or (c) the HQNO is bound to a Q-
binding site which requires Q for activity but does not require physical movement of the Q 
molecule, so that even a covalently linked Q (after photolysis) is still functionally active. 
If the last were true, then HQNO may be bound to the Q-binding site of the Mr=37,000 
protein subunit. This is suggested by the observation that intact ubiquinol-cytochrome c 
reductase, when photolyzed with azido-Q, incorporated azido-Q into the Mr=37 ,000 
protein, but underwent no loss of activity. More experiments are needed before the mode 
of action of HQNO is clear. 
CHAPTER III 
THE NATURE OF THE INillBITION OF 4,7-DIOXOBEN-
WTIITAZOLE DERIVATIVES ON MITOCHONDRIAL 
UBIQUINOL-CYTOCHROME C REDUCTASE 
The indispensability of ubiquinone (Q) in mitochondrial and photosynthetic 
electron transfer has been established (157, 60, 56, 63) and its possible role in proton 
translocation suggested (56, 63). However, the reaction mechanisms of Q in electron 
transfer and proton translocation are not yet understood and are currently the subjects of 
intensive investigation (73,74). A powerful tool for studying the reaction mechanism of Q 
is the use of specific inhibitors (75, 76), particularly Q-like compounds such as 5-n-
undecyl-6-hydroxy-4,7 -dioxobenzothiazole (UHDBT) (153, 35), 
dibromomethylisopropyl-1,4-benzoquinone (DBMIB) (77-80), and other quinone 
derivatives (75). Molecules structurally similar to Q may mimic the function of Q and 
compete with it for binding sites, thus interfering with Q-mediated electron transfer 
reactions. 
UHDBT was first introduced as a specific inhibitor in the NADH or succinate 
oxidase of yeast mitochondria by Roberts et al. (153). Lately it has been used extensively 
in studying mammalian mitochondrial (71, 84) and bacterial photosynthetic electron 
transfer systems (35). This inhibitor is reported to block electron transfer from ubiquinol 
to cytochrome c and to cause alteration of the EPR characteristics of Rieske's iron-sulfur 
protein. 
Although the inhibition mechanism of UHDBT is not known, it has been shown to 
raise the midpoint redox potential (pH 7 .0) of the iron-sulfur cluster of ubiquinol-
52 
53 
cytochrome c reductase from 280 to 350 mV (35, 36). The fact that UHDBT has a 
quinone-like structure and is capable of altering the EPR characteristics of iron-sulfur 
protein has led some investigators (4, 81, 85, 90) to propose that UHDBT binds to 
Rieske's iron-sulfur protein and imply that Rieske's iron-sulfur protein is responsible for 
Q binding in ubiquinol-cytochrome c reductase. However, since the inhibitory effect of 
UHDBT is not reversed by exogenous Q, Q and UHDBT may not bind to the same site. 
Furthermore, recent photoaffinity labeling studies of Q binding proteins using arylazido-
and azido-Q derivatives (61, chapter two) do not support the same site proposal because 
the iron-sulfur protein of the complex was not labeled by azido-Q, and the labeling pattern 
of the Q binding protein was not altered when UHDBT was present in the system. 
To delineate the nature of UHDBT inhibition and to help to understand Q-mediated 
electron transfer, we have synthesized a series of 4,7-dioxobenzothiazole derivatives and 
compared their inhibitory efficacies and their ability to alter the EPR spectra of iron-sulfur 
protein in ubiquinol-cytochrome c reductase. By placing an azido group in the molecule, 
we were able to locate the binding site of this inhibitor after illumination. Herein we report 
the synthesis and properties of several4,7-dioxobenzothiazole derivatives and that the 
binding site of UHDBT in ubiquinol-cytochrome c reductase using 6-azido-5-{ 1', 2'-[3H] 
undecyl}-4,7-dioxobenzothiazole ([3H] 6-azido-UDBT). 
Experimental Procedures 
Materials 
Benzothiazole, 2-amino-6-methoxybenzothiazole, and other organic chemicals 
used in the syntheses were from either Aldrich or Eastman; cytochrome c and silica gel, 
230-400 mesh, from Sigma; silica G thin layer plates, 250 micron, and HPTLC plates 
from Analtech. The Si-5 micropack HPLC column was from Varian. 2,3-Dimethoxy-5-
methyl-6-geranyl-1.4-benzoquinone (Q2) and its reduced form (Q2H2) were synthesized 
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in our laboratory as previously reported (106). Other chemicals were of the highest purity 
commercially available. 
Enzyme Preparations 
Ubiquinone-cytochrome c reductase and its Q- and phospholipid (PL)-depleted 
preparations (107) were prepared and assayed as previously reported. Protein was 
estimated by the Lowry method (108) using crystalline bovine serum albumin as the 
standard. Phosphorus was determined by the method reported by Dubin (143). 
Spectral Measurements 
The absorption spectra were measured in a Cary spectrophotometer, model219, at 
room temperature. NMR spectra were measured using either a Hitachi Perkin-Elmer 
Model R24B or a Varian XL-300 NMR spectrometer. Mass spectra were measured with a 
high resolution CEC21-11 0 B Mass Spectrometer with Nora data acquisition system. IR 
spectra were done with a Perkin-Elmer Grating Infrared Spectrophotometer, model 457. 
EPR measurements were done with a Brucker ER-200D spectrometer. The detailed 
conditions and instrument settings are given in the legend of Fig. 23. 
Synthesis of 4,7-Dioxobenzothiazole Derivatives 
For simplicity of presentation the syntheses of 4, 7 -dioxobenzothiazole derivatives 
are divided into two groups: those with substituents at the 2-position of the 4,7-
dioxobenzothiazoles and those without. The 2-substituted derivatives include 2-bromo-
and 2-azido-5-decyl-6-methoxy-4.7-dioxobenzothiazole, and 2-bromo- and 2-azido-5-
decyl-6-hydroxy-4,7-dioxobenzothiazoles; the 2-unsubstituted derivatives include 6-
bromo- and 6-azido-5-decyl (or undecyl)-4,7-dioxobenzothiazoles. 
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Synthesis of 2-Substituted Derivatives 
The essential steps are outlined in Scheme 1. 
Synthesis of 2-Bromo-6-methoxybenzothiazole (ll). Synthesis of compound II 
from compound I was carried out by the method of Erlenmeyer and Ueberwasser (109). 
Fifteen grams of 2-amino-6-methoxybenzothiazole and 75 ml of 85% H3P04 were placed 
in a three-necked flask equipped with a mechanical stirrer and a thermometer. The mixture 
was warmed to and maintained at 40°C until a clear solution was obtained. The solution 
was then cooled to -10 °C, and 21 ml of cone. HN03 was added. The temperature of this 
mixture was maintained at -12 °C to -8 °C during the addition of HN03. Six grams of 
NaN02 in 7.5 ml of H20 were added in 1-ml portions with a pipette to the bottom of the 
flask. Mter the addition of NaN02, the mixture was stirred for 10 min and then poured 
slowly into 300 ml of HBr solution ( 48%) containing 22.5 g of CuBr at 0°C. After the 
evolution ofN2 ceased, the mixture was stirred for 15 minutes, diluted with three volumes 
of H20, neutralized with 5 N NH40H, and extracted with benzene. The extract was dried 
over anhydrous Na2S04, ~nd benzene was removed by distillation. The residue was 
purified by the silica gel column chromatography (2.5 x 10 em, 230-400 me she), using 
ether-hexane (1:1) as the eluting solvent. The product, 2-bromo-6-methoxybenzothiazole, 
was collected as a purple fraction. The solvent was removed and compound II was 
crystalized from CH30H-H20 as purple needles. The yield was 56%. 2-Bromo-6-
methoxybenzothiazole has a m.p = 56-7°C; 1H NMR (CDCl3): 3.88 (s, 3H), 17.08 
(q.1H), 7.28 (d, 1H), 7.88 (d, 1H). 
Synthesis of 2-Bromo-6-methoxy-4. 7 -dioxobenzothiazole (Ill). Synthesis of 
compound ill from compound ll was carried out essentially according to the method of 
Braude & Fawcett (110). Five grams of 2-bromo-6-methoxybenzothiazole (ll) were 
dissolved in 40 ml of95% acetic acid and placed in a 100 ml three necked flask equipped 
with a mechanical stirrer and thermometer. To this solution, 5 g of chromium trioxide 
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SCHEME 1 
THE SYNTiffiSIS OF 2-SUBSTITUTED DERIVATIVES 
(I) (II) (Ill) 
(IV) (V) 
HBr 
CH3(CH2)s=&N NaNs CH3(CH2)9J(xO N I I }-Br --- I I ~N3 
00 s 00 s 
0 0 
(VI) (VII) 
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were added in small portions at 20°C. The reaction mixture was stirred at 20°C until it 
became dark green (about 30 hrs), poured into 120 ml of H20, and extracted three times 
with ether. The extract was dried over anhydrous Na2S04. After the removal of ether the 
residue was separated by a silica gel column (2.5 x 10 em, 230-400 meshes) using 
hexane-ether (1:1) as the eluting solvent. The yellow fraction was collected, dried, and 
subsequently crystalized from absolute ethanol to yield 50 mg of yellow needle crystals of 
2-Bromo-6-methoxy-4.7-dioxobenzothiazole. The yield was 1%. Compound III shows 
lH NMR (CDCl3): 3.94 (s, 3H), 6.06 (s, lH); IR 1680 cm-1, 1660 cm-1. 
Synthesis of 2-Bromo-5-decyl-6-methoxy-4.7-dioxobenzothiazole (IV). 
Synthesis of compound IV from Compound III was carried out according to the method of 
Friedman et. al. (111). To fifty mg of 2-bromo-6-methoxy-4,7-dioxobenzothiazole (III) 
in 5 ml of glacial acetic acid were added 150 mg of diundecanoyl peroxide and stirred for 5 
hrs at 95°C. The mixture was extracted three times with ether after cooling to room 
temperature. The extract was washed, in sequence, with H20, 1 N HCl, 0.5 M 
NaHC03, and H20 before being dried over anhydrous Na2S04. After the removal of 
ether the residue was separated by TLC developed with benzene-ethanol (95:5). 8 mg of 
2-bromo-5-decyl-6-methoxy-4.7-dioxobenzothiazole (IV) were obtained. Rf = 0.79; lH 
NMR (CDCl3): 0.88 (t, 3H), 1.26 (m, 14H), 1.50 (m), 2.55 (t, 2H), 4.11 (s, 3H); IR: 
2950 cm-1 (s), 2860 (s), 1750 cm-1 (s), 1720 cm-1 (s); UV 95% EtOH: oxi., 295, 248 
nm, red, 260 nm. 
Synthesis of 2-Azido-5-decyl-6-methoxy-4,7-dioxobenzothiazole (V). N aN3 (60 
mg) were added to 4 mg of 2-bromo-5-decyl-6-methoxy-4,7-dioxobenzothiazole (IV), 
dissolved in a solution containing 1.5 ml of EtOH, 1.5 ml of acetone and 0.4 ml of H20, 
and stirred for 5 hours at room temperature in the dark. After the mixture was 
concentrated, it was applied to a TLC plate and developed with hexane-ether (3.5: 1). The 
compound with a Rf = 0.79 was collected, eluted with ether, dried to yield 2 mg of yellow 
oil of 2-azido-5-decyl-6-methoxy-4,7-di<J>xobenzothiazole. UV 95% EtOH: oxi., 308, 
and 272 nm; red., 250 nm. 1 H NMR (CDC13): 0.85 (t, 3H}, 1.25 (m, 14H), 1.45 (m, 
2H), 2.52 (t, 2H), 4.08 (s, 3H). 
Synthesis of 2-Bromo-5-decyl-6-hydroxy-4,7-dioxobenzothiazole (VI). 
Synthesis of compound VI from compound IV was carried out by a modification of the 
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methcx:i reported by Clarke et .al (112). Five mg of 2-bromo-5-decyl-6-methoxy-4,7-
dioxobenzothiazole (IV) in 10 ml of glacial acetic acid were treated with 10 ml of 
hydrobromic acid ( 48%) and stirred for 5 hrs at 45°C. The mixture was poured into 200 
ml of H20 and extracted twice with ether. The extract was washed twice with H20 and 
dried over anhydrous Na2S04. After the solvent was removed, the residue was dissolved 
in 1 ml of acetone and applied to a TLC plate developed with hexane-ether ( 1: 1 ). The 
compound with a Rf = 0.70 was collected, eluted with ether, and dried to yield 4 mg of 
yellow oil of 2-bromo-5-decyl-6-hydroxy-4,7-dioxobenzothiazole. UV 95% EtOH: oxi., 
295,251 nm; red., 261 nm; IR: 1720 cm~1 (s). 1H NMR (CDC13): 0.90 (t, 3H), 1.29 
(m, 12H), 1.52 (m, 2H), 1.65 (m, 2H), 2.58 (t, 2H). 
Synthesis of 2-Azido-5-decyl-6-hydroxy-4,7-dioxobenzothiazole (VII). To 2.4 
mg of 2-bromo-5-decyl-6-hydroxy-4.7-dioxobenzothiazole (VI) in a solution containing 
400 J.Ll of EtOH, 400 Jll of acetone, and 200 J.Ll of glacial acetic acid, was added 20 mg of 
NaN3 in 200 J.!l of H20. After stirring for 10 hrs at room temperature the mixture was 
applied to a TLC plate and developed with hexane-ether (3.5:1). The band with a Rf= 
0.72 was collected, eluted with ether, and dried to yield 1 mg of yellow oil of 2-azido-5-
decyl-6-hydroxy-4,7-dioxobenzothiazole. The yield was 40 %,. Compound VII has UV 
95% EtOH: oxi, 312 and 260 nm; red., 264 nm; IR, 2250 cm-1. 1H NMR (CDCl3): 
0.88 (t, 3H), 1.25 (m, 14H), 1.52 (m, 2H), 2.55 (t, 2H). 
Synthesis of 2-Unsubstituted Derivatives 
The essential steps involved in the synthesis of 2-unsubstituted derivatives, 6-
bromo- and 6-azido-5-decyl (or undecyl)-4,7-dioxobenzothiazole, are outlined in 
Scheme 2. 
59 
Synthesis of 6-Bromo-4. 7 -dioxobenzothiazole (XIV). 6-Bromobenzothiazole 
(XI) was prepared from benzothiazole (Vill) by nitration, reduction, and diazotization 
according to the procedure reported by Boggust et al (113). 7-Amino-6-
bromobenzothiazole (XIll) was synthesized from 6-bromobenzothiazole (XI) by the 
procedure reported by Haddock et. al (114). To 2.7 g of 7-amino-6-bromobenzothiazole 
(XIII) dissolved in 450 ml of 3.44 N H2S04 was added 60 ml of 10% Na2Cr207, over 
1.5 hrs, at 3°C. After stirring at room temperaturefor 10 hrs the dark brown precipitate 
was removed by filtration and the filtrate was extracted three times with ether. The extract 
was washed three times with H20 and dried over anhydrous Na2S04. 0.2 g of yellow 
plate crystals of 6-bromo-4,7 -dioxobenzothiazole were obtained after ether removal and 
crystallization from EtOH. The product has m.p.= 188-189°C, 1H NMR (CDCl3): 7.47 
(s, 1H), 9.16 (s, 1H). 
Synthesis of 6-Bromo-5-decyl (or undecyD-4.7-dioxobenzothiazole (XV or XVI2. 
To twenty mg of 6-bromo-4,7-dioxobenzothiazole (XIV) in 4 ml of glacial acetic acid 
were added 60 mg of diundecanoyl peroxide (or dilauroyl peroxide). After stirring at 
95°C for 13 hrs the mixture was extracted three times with ether. The extract was 
washed, in sequence, with H20, 1 N HCl, 0.5 M NaHC03, and H20 twice before being 
dried over anhydrous Na2S04. After ether removal the residue was applied to a thin layer 
plate and developed with hexane-ether (1:1). The band with a Rf = 0.43 (XV or XVI) 
was collected and eluted with ether to yield 1.6 mg of XV (or XVI). XV has 1H NMR 
(CDCl3): 0.88 (t, 3H), 1.27 (m, 12H), 1.43 (m, 2H), 1.57 (m, 2H), 2.84 (t, 2H), 9.12 
(s, 1H); UV EtOH: 285 and 230 nm. XVI has 1H NMR (CDC13): 0.91 (t, 3H), 1.29 
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SCHEME 2 
1HE SYNTIIESIS OF 2-UNSUBSTITUTED DERIVATIVES 
aN HNO, LVl- s ~ _H_2_s_o-. 
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(XV) R = decyl (XVII) R = decyl 
(XVI) R = undecyl (XVIII) R = undecyl 
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(m, 14H), 1.46 (m, 2H), 1.60 (m, 2H), 2.88 (t, 2H), 9.14 (s, 1H); UV EtOH: 290, 231 
nm. 
Synthesis of 6-Azido-5-decyl (or undecyl)-4.7-dioxobenzothiazole (XVII or 
XVIII). To 1.6 mg of 6-bromo-5-decyl-4~7-dioxobenzothiazole (or 6-bromo-5-undecyl-
4,7-dioxobenzothiazole) in a solution containing 200 Jll of ethanol, 200 Jll of acetone, and 
70 Jll of water was added 1 mg of sodium azide. Mter stirring at room temperature in the 
dark for 12 hrs, the mixture was applied to a thin layer plate and developed with hexane-
ether (1:1). The band with a Rf = 0.39 (XVII or XVIII) was collected and eluted with 
ether to yield 0.8 mg of 6-azido-5-decyl (or undecyl}-4,7-dioxobenzothiazole. 1H NMR 
of XVII (CDCl3): 0.75 (t , 3H), 1.25 (m, 12H), 1.47 (m, 2H), 1.56 (m, 2H), 2.57 (t , 
1 . 2H), 9.12 (s, 1H ). H NMR of XVIII (CDC13): 0.86 (t, 3H), 1.26 (m, 14H), 1.47 (m, 
2H), 1.56 (m, 2H), 2.57 (t, 2H), 9.11 (s, 1H). 
Isolation of 6-N:3:-UDBT Bound Phospholipid 
Ubiquinol-cytochrome c reductase or its delipidated preparation, 1.5 mglml, in 50 
mM Na/K. phosphate buffer, pH 7.4, containing 10% glycerol and 0.5% sodium cholate 
was incubated with a five-molar excess 6-azido-5-{ 1', 2'-[3H]-undecyl}-4,7-
dioxobenzothiazole { [3H]-6-N3-UDBT} in the dark for 10 min. at 0 °C. Under these 
conditions, about 40% of the enzyme activity is inhibited when intact ubiquinol-
cytochrome c reductase is used; about 75% of the reconstituted activity is inhibited when 
delipidated ubiquinol-cytochrome c reductase is used and assayed after reconstitution with 
phospholipid (asolectin) and Q. The [3H]-6-N3-UDBT-treated sample was transferred to 
a photolysis apparatus made of two quartz glasses sandwiched by a Teflon ring and 
illuminated with a long UV light at 0 °C for 10 min (chapter two). The photolyzed 
complex was then extracted twice with a chloroform-methanol (2: 1) mixture to remove 
phospholipid from its protein fraction. All the radioactivity was found in the extract which 
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was dried, applied to a thin layer plate and developed with ether to remove non-
phospholipid materials. Three parallel control experiments were run: (a) [3H]-azido-
UDBT in the same buffer and photolyzed in the absence of reductase; (b) reductase in the 
same buffer photolyzed in the absence of [3H]-azido-UDBT; and (c) asolectin in the same 
buffer photolyzed with [3H]-azido-UDBT. The phospholipid fraction was collected, 
dried, dissolved in chloroform-methanol (2:1), and applied to a Si-5 Micropak: HPLC 
column. The column was eluted with a gradient formed from a mixture of 
hexane:isopropanol (97:3) and a mixture ofhexane:isopropanol (60:40). One-ml fractions 
were collected and [3H]-radioactivity was determined. 
Identification of Fatty Acids of the Azido-UDBT 
Linked Phospholipid 
150 ~g of the [3H]-azido-UDBT linked phospholipid fraction obtained by HPLC 
were dried, dissolved in 4 ml Na-dried benzene, and added to 0.4 m1 of HCl-CH30H and 
0.5 m1 of 2,2-dimethoxyl-propane. The mixture was kept at room temperature overnight, 
after which the solvents were removed with a stream of nitrogen. The methyl esters of the 
fatty acids were identified by capillary gas' chromatography, Tracor 560 (115) 
Identification of the Head Group of the 
Azido-UDBT Linked Phospholipid 
The head group of phospholipid was determined by the method of Latyshev and 
Vaskovsky (116) with slight modifications. To 10 ~g of the [3H]-azido-UDBT linked 
phospholipid in 40 ~1 of carbon tetrachloride were added, in sequence, 380 ~1 of ethanol, 
33 ~1 of H20, and 12.5 ~1 of 1 N NaOH. The mixture was incubated at 37 °C for 20 min, 
treated with 20 ~1 of ethyl formate to neutr;ilize the excess alkaline, and incubated for 
another 5 min at 37 °C. The solution was dried with a N2 stream, and the residue was 
dissolved in 300 ~1 chloroform-isobutanol (2:1, v/v) saturated with H20 and partitioned 
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with 300 !J.l of water saturated with chloroform-isobutanol (2:1) by shaking. The H20 
layer was separated from the chloroform-isobutanollayer by centrifugation, collected, and 
concentrated to 50 J.ll. Three-Jll of this solution, along with glycerophosphoryl choline, 
glycerophosphoryl ethanolamine and diglycerophosphoryl glycerol hydrolized from 
standard phospholipids, were applied to a 5 x 5 em High Performance TLC-HL plate and 
developed with MeOH: CH3COCH3: CHCl3: H20: NH40H (10:4:4:1:2, v/v). The 
plate was air dried, sprayed with HCl04 and placed on a hot plate at a surface temperature , 
of 250 -300°C until the plate became white. After the plate was cooled to room 
temperature, it was spr~yed with Malachite Green and kept it in a desiccator. The 
background became orange and the spots with phosphate became bright green. 
Results and Discussion 
Synthesis, Structure, and Properties of 
4, 7-Benzothiazole Derivatives 
The 4,7-dioxobenzothiazole derivatives used in this study were synthesized by two 
general routes: route I for compounds having the substituent at the 2-position of the 4,7-
dioxobenzothiazole ring, such as 2-bromo- and 2-azido-5-decyl-6-methoxy (or hydroxy)-
4,7-dioxobenzothiazole, and route II for compounds possessing no substituent at the 2-
position of the ring, such as 6-bromo-and 6-azido-5-decyl (or undecyl)-4,7-
dioxobenzothiazole (Schemes 1& 2). The overall yields are low because no effort was 
made to maximize the yield of each synthetic step. However, they can be improved if 
reaction conditions are carefully chosen. In general, the synthetic procedures reported 
here are satisfactory since only a small am aunt of the compound is needed for the study. 
An attempt to synthesize 2-bromo-6-methoxy-4,7-dioxobenzothiazole from 2-
bromo-6-methoxybenzothiazole through nitration, reduction and oxidation (scheme 3) was 
SCHEME 3 
AN UNSUCCESSFUL PATHWAY OF THE SYNTIIESIS OF 
2-BROM0-6-IviElliOXY -4,7-DIOXOBENzonnAZOLE 
SnC12, HCl 
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made. It was not successful. The bromine at position 2 is subjected to hydrogenolysis 
when the nitro group at position 7 is reduced (Fig. 16). 
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Table V summarizes the chemical structure, UV and NMR spectral properties, and 
inhibitory efficacies of these 4,7-dioxobenzothiazole derivatives. 5-Undecyl-6-hydroxy-
4,7-dioxobenzothiazole (UHDBT) shows 'a UV absorption peak at 285 nrn with a 
shoulder at 248 nm in 95% ethanol. Replacing the 5-undecyl group with decyl group 
(DHDBT) causes no change in the UV absorption characteristics. Replacing the 6-
hydroxyl group with a bromo group (6-Br-UDBT) causes a 5 nm red-shift of the peak 
with a 15 nm blue-shift of the shoulder absorption. Replacing the 6-hydroxyl group with 
a methoxyl group(UMDBT) or an azido (6-N3-UDBT) causes a red-shift of both the peak 
and shoulder absorptions. It should be noted that the spectral shift caused by the change 
of the 6-hydroxyl of DHDBT is the same as those observed with UHDBT. Introducing a 
bromo atom or an azido group to the 2-position ofDHDBT molecule also results in a red-
shift of both the peak and shoulder absorptions. 
As expected, photolysis of azido- derivatives, such as 2-azido-5-decyl-6-hydroxy-
4,7-dioxobenzothiazole (2-N3-DHDBT) or16-N3-UDBT, results in a drastic decrease in 
the UV absorption intensity. Fig. 17 show~ the absorption spectra of 6-N3-UDBT and its 
photolyzed products in 95% ethanol. 
All these 4,7-dioxobenzothiazole derivatives show inhibitory effects on ubiquinol-
cytochrome c reductase with different potencies. When purified ubiquinol-cytochrome c 
reductase is treated with a 10-fold excess ofUHDBT per mole of cytochrome b, about 
90% of the enzymic activity is lost Replacing the 6-hydroxyl ofUHDBT with a bromo or 
with an azido group decreases the inhibition potency by 10% and 50%, respectively, 
indicating that the 6-hydroxyl is not a structural requirement for inhibition. 
Although introducing a bromo in the 2-position of DHDBT molecule causes a 
decrease in inhibition potency by 10%, subsequently replacing the 6-hydroxyl with a 
methoxy increases the inhibition efficacy to the same level as that of UHDBT. Introducing 
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Fig. 16. Bromine Was Removed with Reduction of the Nitro Group 
TABLE V 
STRUCfURE, SPECI'RAL, AND INHIBITORY PROPERTIES OF 4,7-
DIOXOBENWTIDAZOLE DERIVATIVES 
General Structure 
0 R5VN I I ~R2 
R6 s 
eo.,o....s Rl IU R6 ~.,.EIOH NMR Inhibition• ... 
... 
UHDBT H OIJ(CHl)JoH OH l8S, 246 0.90 (1), 1.26 (m), 2.39 (1), 9.14 (1). 90 
DHD8T H CIIJ(CH2)9H OH 283,246 0.88 (1), 1.23 (m), 1.52 (m), 2.39 (1), 9.14 (1). 80 
._Br·UDBT H CHJ(CH2ltoH Br 290,231 0.91 (1), 1.29 (m), 1.46 (m), 1.60 (m), 2.88 (1), 9.14 (1) 80 
.. IINXIBT H CH3(CH2)9H Br 285,230 0.88 (1), 1.27 (m), 1.43 (m), 1..57 (18), 2.14 (1), 9.12 (1) 75 
.. N)·UDBT H CHJ(CH2l1oH N) lOS, 238 0.16 (1), 1.26 (m), 1.47 (.,), 1.56 (18), 2..57 (1), 9.11 (o). 42 
.. N)·DDBT H CHJ(CIIz)9H N3 305,259 0.75(1), 1.25 (m), 1.47 (m), 1.56 (.,), 2..57 (1), 9.12 (1) 40 
~T H CH3(CIIzltoH CH)O 219,233 O.U (1), 1.26 (m), 1.45 (m), 2.56 (1), 4.10 (1), 9.06 (1) ., 
2-Br-DHDBT Bt CH3(CH2)9H OH 295,231 0.90 (1), 1.29 (m), 1.52 (m), 1.65 (m), 2.51 (1). 80 
l·Br-DMDBT Br CH3(CH2)9H CH30 295,241 0.88 (I), 1.26 (m), I.SO (m), 2.55 (I), 4.1 t (I) 90 
2-NJ·DHDBT N) CH3(CH2)9H OH 312,260 0.11 (1), 1.23 (m), 1..52 (m), 2.55 (1). 90 
l·NJ·DMDBT N) CHJ(CH%)9H CH30 301,272 o.aa (1), 1.23 (m), 1.43 (m), 2..52 (1), 4.10 (o). 64 
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Fig. 17. Absorption Spectra of 6-Azido-UDBT. 50 JlM of 6-azido-
UDBT in 95% ethanol was used. Solid line ( -) 
represents oxidized form; broken line (- -)represents 
sample being illuminated with long UV light for 10 min. 
at 0 ·c. 
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an azido group to the 2-position ofDHDBT does not decrease the inhibitory potency, 
whereas introducing an azido at the 2-position ofDMDBT decreases inhibition by 21%. 
These results indicate that an unsubstituted 2-position is not necessary for UHDBT 
inhibition. It should be mentioned that the data given in Table 3 for the inhibition of 
ubiquinol-cytochrome c reductase by these derivatives are the maximum inhibitions 
obtained All these derivatives show maximum activity inhibition when 10 moles of the 
derivative per mole of cytochrome b. are used. 
Effect of pH on the Inhibitory Efficiency of 
4. 7-Dioxobenzothiazole Derivatives 
It has been reported (71) that inhibition of mitochondrial ubiquinol-cytochrome c 
reductase by UHDBT is pH dependent. Maximum inhibition was observed when 
ubiquinol-cytochrome c reductase was reacted with UHDBT at a pH around 6.5; little 
inhibition was observed when the reacting
1
pH was above 7.5. Since the pKa for the 6-
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hydroxyl of UHDBT is 6.5 (71), the observed pH-dependency was attributed to the 
dissociation state of the 6-hydroxyl of UHDBT. That is, the non-dissociated (protonated) 
form of 6-hydroxy of UHDBT is essential for inhibition. One way to fmd out whether or 
not dissociation of the 6-hydroxyl group is responsible for the pH-dependent inhibition 
observed with beef heart mitochondrial ubiquinol-cytochrome c reductasde is to study the 
pH effect of derivatives bearing a nondissociable group at the 6-position, such as 6-Br-
UDBT. Fig 18 shows the results of such a study using 6-Br-UDBT and UHDBT. When 
beef heart mitochondrial ubiquinol-cytochrome c reductase at various pH's is treated with 
6-Br-UDBT, the percent inhibition decreases as the pH increases, just as when UHDBT is 
used. Obviously pH dependent inhibition is not due to the dissociation of the 6-hydroxyl 
group. Rather, it must be due to a change r-vhich occurs in the enzyme molecule. Very 
I 
I 
likely the binding of UHDBT involves a group having a pKa of around 6.5 in the enzyme 
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Fig. 18. Effect of pH on the Inhibitory Efficacy of UHDBT and 6-Br-
UDBT. 0.2 mlaliquots of ubiquinol-cytochrome c reductase, 2 
mg/ml (20 ~M of cytochrome b), in 50 mM phosphate buffer 
containing 10% glycerol and 0.5% sodium cholate at indicated 
pH's were added UHDBT (-o-) or 6-Br-UDBT (-6-). The 
molar ratio of inhibitor to cytochrome b used was 10: 1. The 
mixture wasincubated at 0 ·c for 20 min. before the enzymatic 
activity was assayed. ThepH of the assay mixture used 
corresponds to that of the incubating solution. 
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complex, such as a histidyl residue, or is affected by a dissociable group with a pka of 6.5 
located close enough to induce the change of the inhibitor binding site or domain. 
Effect of 4.7-Djoxobenzothiazole Deriyatiyes on the EPR 
Characteristics of Iron Sulfur Protein 
It was reported (36) that inhibition of ubiquinol-cytochrome c reductase by 
UHDBT was accompanied by a down-field shift of the gz (2.02 - 2.03) and up-field shift 
of the gx (1.80 - 1.76) ofRieske's iron sulfur protein. The g's of iron sulfur protein in 
ubiquinol-cytochrome c reductase treated with these 4,7-dioxobenzothiazole derivatives 
are summarized in Table VI. Like UHDBT, inhibition by 4,7-dioxobenzothiazole 
derivatives is accompanied by an up-field shift of the gx of iron sulfur protein in the 
reductase. The correlation between inhibition and the effect on the gx of iron sulfur 
protein makes these derivatives, especially those bearing azido groups, good tools for 
studying the UHDBT action (binding) site. 
Interaction between Azide-Derivatives and 
Ubiquinol-Cytochrome c Reductase 
From Table V it is clear that among the three azido derivatives, 2-azido-DHDBT 
has the highest inhibitory potency (90%) on ubiquinol-cytochrome c reductase in the dark. 
However, when this sample is subjected to illumination at 0 oc for 10 min, there was no 
inhibition. There were at least two plausible explanations; (a) the formation of a covalent 
linkage between the reductase and 2-azido-DHDBT upon illumination alters the structure 
of the inhibitor such that it loses its inhibitory function; (b) the photolysis process causes 
molecular rearrangement of 2-azido-DHDBT to a tetrazole isomer (see Fig. 19) which 
does not inhibit. In fact when ubiquinol-cytochrome c reductase was incubated with 2-
azido-DHDBT which has been stored at 4 oc overnight or with 2-azido-DHDBT which 
has been subjected to photolysis, no inhibition is observed, indicating that the conversion 
TABLE VI 
EFFECf OF 4,7-DIOXOBENZOTHIAZOLE DERIVATIVES ON 
ENZYMATIC ACTIVTIY AND EPR CHARAcTERISTIC 
OF UBIQUINOL-CYTOCHROME c REDUCfASE 
Derivatives Concenttation Used Inhibition. % EPR Signal of ISP 
Added _XlJI.)BTjcyt. b intact (delipiated)*- &z gy &x 
None 0 0 ( 0) 2.018 1.890 1.801 
UHDBT 10 90 (95) 2.025 '1.890 1.775 
6-Br-UDBT 10 82 (90) 2.025 1.944 1.775 
6-N3-UDBT 10 40 (80) 2.020 1.890 1.765 
• The activity was detennined after the XUDBT derivative-treated delipidated ubiquinol-
cytochrome c reductase was ~onstituted with phospholipid (0.5 mg micelle asolectin per mg 
protein) and incubated at 0 ·c for 20 min. _ 
-...) 
N 
Stability 
Photosensitivity 
Inhibitory Effect 
UV Absorption (nm) 
Stable at RT 
·+ 
+ 
312,260 
COld 
R.T. 
Stable at Cold 
295,284 
Fig. 19. Azido-Tetrazole Tautomerism of 2-Azido-DHDB 
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of 2-azido-DHDBT to a tetrazole isomer occurs in the cold or upon photolysis. Therefore, 
2-azido-DHDBT and 2-azido-UHDBT are not suitable compounds for probing the 
UHDBT binding site by photoaffinity labeling. 
6-Azido-UDBT is the least potentinhibitor ofubiquinol-cytochrome c reductase; it 
only inhibits 40% of the activity when incubated with intact ubiquinol-cytochrome c 
reductase in the dark. illumination of the 16-azido-UDBT-treated sample does not alter the 
extent of inhibiton. Surprisingly, when a PL- and Q-depleted ubiquinol cytochrome c 
reductase (about 90% of PL and 95% of Q are removed) is treated with a 10-fold excess of 
6-azido-UDBT per mole cytochrome b followed by reconstitution with Q and 
phospholipid, about 80% of the reconstituted activity is inhibited (see Table V), indicating 
that the PL in the reductase hinders the binding of 6-azido-UDBT to its binding site. Fig. 
20 shows the titration of the Q- and PL-depleted ubiquinol-cytochrome c reductase with 
varying concentrations of 6-azido-UDBT and UHDBT. The ubiquinol-cytochrome c 
reductase activity is measured after the treated sample is reconstituted with asolectin. The 
inhibition behavior of 6-azido-UDBT is similar to that of UHDBT. A 50% inhibition is 
observed when two moles of 6-azido-UDBT per mole of cytochrome bare used. This is 
i 
only a slightly higher ratio than what UIII)BT needs to reach the same level of inhibition. 
6-Azido-UDBT is thus suitable for photoalffinity labeling studies. 
Correlation between 6-Azido-UDBT Uptake by Phospho-
lipid and Inhibition of Enzymatic Activity 
Fig. 21 shows the concentration-dependent incorporation of radioactive [3H]-6-
azido-UDBT into ubiquinol-cytochrome c reductase phospholipid and inhibition of 6-
azido-UDBT-treated ubiquinol-cytochrome c reductase. When intact or PL- and Q-
depleted ubiquinol-cytochrome c reductase is treated with increasing concentrations of 
[3H]-6-azido-UDBT and subjected to illumination for 10 min at 0°C, the ubiquinol-
cytochrome c reductase activity decrease correlates with the increase in [3H]-6-azido-
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Fig. 20. Concentration-dependent Inhibition of Ubiquinol-cytochrome 
c Reductase by l,JHDBT and 6-azido-UDBT. 0.2 ml 
aliquots of the Q- and PL-depleted ubiquinol-cytochrome c 
reductase, 1 mg/ml (10 11M cytochrome b), in 50 mM 
Na/K phosphate buffer, pH 7.4, containing 10% glycerol 
were addedlO Jllof95% ethanol containing indicated 
concentration of tJHDBT ( -o-) or 6-azido-UDBT ( -,1-). 
After incubation at 0 ·c for 10 min., 10 11M of 
micelleasolectin (10 mg/ml) were added. Ubiquinol-
cytochrome c reductase activitywas assayed after the 
mixture was incubated for 20 min. at 0 ·c. The assay 
mixture contains 50 J.l.M Q2H2. 
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Fig. 21. Correlation between 6-Azido-UDBT Incorporation and Activity Inhibition. To 0.2 
ml aliquots of intact (.1.,£) and delipidated (O,e) ubiquinol-cytochrome c 
reductase, 2 mg/ml, were added 10 Jl,l of 95% ethanolic solution containing 
indicated concentration of [3H]-azido-UDBT. After incubation at 0 °C for 20 
min, they were illuminated with a long UV light for 10 min at 0 oc. 
Twenty-J,J.l aliquots were withdrawn from the ~do-UDBT treated intact 
reductase samples, diluted with 400 J.1.l of 50 mM phosphate buffer, pH 7.4, 
containing 0.5% sodium chelate, and assayed for ubiquinol-cytochrome c 
reductase activity (.1.); 20 J.Ll aliquots were withdrawn from the azido-UDBT 
treated delipidated reductase samples, reconstituted with 2 J.Ll of micelle 
asolectin (10 mg/ml) and assayed the activity (-0-) after incubation at 0 ·c for 
20 min. The remaining solutions were extracted three times with 1 ml of 
chloroform: methanol (2: 1), and spotted on a TLC plate. The plate was 
developed with ether to remove the free form, and detergent adduct of 
photolyzed [3H]-azido-UDBT. After developed with ether, the spot at the 
original place was scrapped from the plate, eluted with chloroform:methanol 
(2: 1), and phosphorus and radioactivity determined. Curves with solid triangles 
(-£-)and solid circle (-e-) represent mole of 6-azido-UDBT uptake per mole 
phosphorus in the intact and delipidated reductase, respectively. 
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UDBT uptake by phospholipid. No radioactivity is found in the protein of ubiquinol-
cytochrome c reductase. It should be noted that when PL-and Q-depleted reductase is 
used, the activity is measured after the azido-UDBT treated sample is reconstituted with 
phospholipid and Q. 6-Azido-UDBT gives greater inhibition and radioactivity 
incorporation per mole of phosphorus when used with PL- and Q-depleted reductase than 
with intact reductase. This suggests that UHDBT is bound to phospholipid(s) that are 
tightly bound to the ubiquinol-cytochrome c reductase protein. The PL-and Q-depleted 
preparation still contains 10% of the phospholipid, the majority of which was reported to 
be cardiolipin ( 117). 
Bindin~ of 6-Azido-UDBT to Cardiolipin of 
Ubiqyinol-Cytochrome c Reductase 
Fig. 22 shows the radioactivity distribution in the HPLC chromatogram of 
phospholipid obtained from photolyzed, [3H]-6-azido-UDBT-treated ubiquinol-
cytochrome c reductase. When analyzed by HPLC using a Micropak Si 5 column eluted 
I 
with a gradient formed from hexane-isopropanol (97 :3) and hexane-isopropanol (60:40), 
most of the radioactivity is found in fraction 46. The peak height as well as that 
radioactivity in fraction 46 increases as the percent inhibition by [3H]-6-azido-UDBT 
increases (data not shown), indicating that the UHDBT binding site is located in this 
fraction. 
The fraction containing radioactivity was shown to be a phospholipid-UDBT 
adduct by identification of phosphorus and fatty acid. When the fraction was methyl 
esterified and subjected to HPLC analysis under the same conditions, the peak was split 
and eluted earlier. The head group of this phospholipid fraction was identified as 
diglycerophosphorylglycerol. 6-Azido-UDllT was linked to the acyl group and not to the 
head group of the cardiolipin molecule because when the radioactivity-containing 
phospholipid fraction was subjected to methyl esterification and then partitioned with 
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Fig. 22. [3H]-radioactivity Distribution on the HPLC Chromatogram of Ubiquinol-
Cytochrome c reductaSe Phoapholipids. Ubiquinol-cytochrome c reductase, 1 
mg/ml (10 I.I.M cytochrome b), in 50 mM K/K phoaphate buffer, pH 7.4, 
containing 10% glyc~rol and 0.5% sodium chelate, was treated with [3H]-
azido-UDBT in 95% ethanol at 2 moles inhibitor per mole cytochrome b. 
After incubation for 20 min at 0 °C, the [3H]-azido-UDBT treated sample was 
subjected to illumination with long UV light for 10 min at 0 °C. The 
illuminated sample was extracted twice with chloroform:methanol (2:1). The 
extract was dried, applied to a TLC plate developed with ether to remove non 
phospholipid materials. The phospholipid wac; collected, dried, dissolved in 
chloroform:methanol (2:1), and applied to a Micropak Si-5 HPLC column. 
The column was eluted with a linear gradient fcamed from hexane-isopropanol 
(97:3) and hexane-isopropanol (60:40) at a flow rate of 1 ml/min. One-ml 
fractions were collected and radioactivity detennined. 
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ether, the radioactivity was found in the ether layer. The purified [3H]-azido-UDBT 
linked cardiolipin fraction had an azido-UDBT to phosphorus ratio of 1:2, indicating that 
only one of the four fatty acyl groups was linked to 6-azido-UDBT since one 
diphosphatidyl glycerol molecule contains four fatty acyl groups and two phosphates. 
Identification of the fatty acyl group which binds to 6-azido-UDBT has been hindered by 
the complexity of the photochemistry of the azido compound. When the fatty acyl ester, 
prepared from [3H]-azido-UDBT-linked cardiolipin, was analyzed by gas 
chromatography, a rather complicated chromatogram was observed. Two peaks with 
retention times corresponding to normal C16 and C18 methyl esters were detected. 
Apparently these are not covalently linked with [3H]-6-azido-UDBT, but they were fatty 
acyl groups of cardiolipin, because the methyl ester of a azido-UDBT-linked fatty acyl 
group would be expected to have different chromatographic behavior. 
Isolated, fully active mitochondrial ubiquinol-cytochrome c reductase contains 
about 0.2 mg phospholipid per mg protein. About 90% of the phospholipid and 95% of 
the Qw present in the preparation can be removed by repeated ammonium sulfate 
fractionation in the presence of cholate. The resulting delipidated preparation shows no 
ubiquinol-cytochrome c reductase activity. Addition of phospholipid (asolectin) to the 
delipidated preparation completely restores the enzymatic activity, indicating that 
phospholipids which are removed by this delipidation procedure are important, but not 
structurally indispensable, since they can be replaced. Removal of the residual 
phospholipid from the deplipidated preparation requires more drastic conditions and 
results in an irreversible denaturation, indicating that phospholipids present in 
reconstitutively active, delipidated reductase are in a specific environment and structurally 
indispensable. The detection of 6-azido-UDBT-link.ed cardiolipin in PL-and Q-depleted 
reductase and the fact that UHDBT inhibits ubiquinol-cytochrome c reductase activity of 
delipidated reductase assayed after reconstitution with Q and PL indicate that the UHDBT-
perturbed cardiolipin molecule is structurally indispensable to reductase and is tightly 
associated with the reductase protein. The involvement of phospholipid in antimycin 
binding to yeast ubiquinol-cytochrome c reductase has been reported (118). 
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Although at present the identity of the protein subunit(s) of ubiquinol-cytochrome c 
reductase which is associated with this specific cardiolipin is not known, it is reasonable to 
assume that such a protein subunit(s) requires phospholipid for structural integrity. 
Among the components of reductase, cytochrome b is the most phospholipid requiring 
protein. It needs phospholipid for both functional activity and structural integrity. When 
intact ubiquinol-cytochrome c reductase phospholipid is mostly removed by the repeated 
cholate-ammonium sulfate fractionation, the spectral and redox properties of cytochrome b 
(though not cytochrome q or Reiske's iron sulfur protein) are seriously altered. These 
altered spectral and redox properties are restored upon replenishment with phospholipid. 
Complete removal of phospholipid from the delipidated preparation causes the irreversible 
denaturation of cytochrome b. So far, all ,the isolated cytochrome b preparations contain 
no phospholipid and are functionally inactive. On the other hand, isolated cytochrome c 1 
(119) or iron sulfur protein (120), contains no phospholipid but does maintain the same 
redox properties, indicating that these two proteins do not depend on phospholipid to 
maintain their structure. This, however, does not rule out the functional requirement of 
I 
' 
phospholipid for these proteins. These facts, together with the structural similarity 
between UHDBT and quinone, suggest that this specific cardiolipin is associated with the 
Q-binding proteins (b cytochrome and/or a Mr = 9, 507 dalton subunit 2) of ubiquinol-
cytochrome c reductase and may represent part of the Q-binding site or domain. 
Perturbation of this cardiolipin molecule by binding to UHDBT alters the Q binding 
domain, causing the inhibition of ubiquinol-cytochrome c reductase. In this case, the 
observed alteration of the EPR characteristics of iron sulfur protein in ubiquinol-
cytochrome c reductase treated with UHD~T may result from a secondary effect exerted 
by a third component whose structure depends on the presence of phospholipid. This 
possibility is further supported by the resu,lts ofEPR studies of iron sulfur protein in PL 
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sufficient- and deficient-ubiquinol-cytochrome c reductases treated with UHDBT. As 
shown in Fig. 23. the EPR spectrum of iron sulfur protein in UHDBT -treated, PL-
sufficient ubiquinol-cytochrome c reductase resembles the EPR spectrum of iron sulfur 
protein in the delipidated reductase. The addition of UHDBT to delipidated reductase does 
not cause further alteration of the EPR spectrum of iron-sulfur protein. This 
phospholipid-dependent UHDBT effect is similar to that observed with 2,5-dibromo-3-
methyl-6-isopropyl-1,4-benzoquinone (DBMIB) except that the effect ofDBMIB on EPR 
characteristics of iron sulfur protein in PL-sufficient reductase is more profound (80). The 
effect ofDBMffi is believed to exert through a PL-dependent component, such as b 
cytochrome or the Q-binding proteins. The UHDBT effect probably results from the 
change of phospholipid environment of the Q-binding proteins (cytochrome b and/or the 
Mr= 9.5 Kd subunit) through the binding ofUHDBT to its action site (cardiolipin), 
indirectly causing a conformational change in a nonphospholipid dependent component 
(iron sulfur protein) and showing a discernible change in the EPR characteristics of the 
iron sulfur cluster. 
Since UHDBT inhibition is accompanied by a change in the EPR characteristics of 
iron sulfur protein, it is also possible that this specific cardiolipin is associated with the 
iron sulfur protein of ubiquinol-cytochrome c reductase. This possibility is, however, less 
likely because isolated, reconstitutively active iron sulfur protein (120, 27) does not 
require phospholipid for structural integrity and has EPR characteristics (80, 27) similar to 
those of the iron-sulfur protein in delipidated ubiquinol-cytochrome c reductase. No EPR 
spectrum alternation is observed upon treatment of isolated iron sulfur protein with 
UHDBT, regardless of the additions of phospholipid made before or after the treatment. 
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Fig 23. Effect of illiDBT on t~ EPR spectra of Iron-Sulfur Protein of Intact 
and Delipidated Ubiquinol-Cytochrome c Reductase. 0.3 ml 
aliquots of ascorbate.reduced ubiquinol-cytochrome c reductase, 
20 mglml, in 50 mM Tris-acetate buffer, pH 7.8, containing 10% 
glycerol were treated with 10 ~of 95% ethanol containing (a) 
none, (b) 10 fold molar excess ofilliDBT. Spectra (c) and (d) 
are the same as (a) and (b) except delipidated reductase was used. 
The EPR instrument settings were: modulation frequency, 100 
KHz, modulation amplitude, 6.3 gauss; microwave frequency, 
9.38 gHz; microwav~ power, 20 mW; scan rate, 5 gauss/sec. 
Spectra were record~ at 80 K. 
CHAPTER N 
SYNTHESIS AND BIOLOGICAL PROPERTIES OF 
FLUORO SUBSTITUTED UBIQUINONE 
DERNATIVES 
The relevent abundance of ubiquinone compared with other redox components in 
the inner mitochomdrial membrane has indicated that ubiquinone may function as a 
homogeneous mobile carrier which shuttles electrons between the complexes. Most of the 
studies concening the function of ubiquinone have concentrated on a dynamic or kinetic 
approach (125-130), which support the idea of the pool function of ubiquinone. Success 
in the identification of the Q-binding proteins in mitochondrial ubiquinol-cytochrome c 
reductase (61, chapter two and three) indicates that the reduction of ubiquinone or 
oxidation of ubiquinol in the electron transfer chain requires the participation of specific 
proteins to provide specific Q-binding sites. It seems that the existence of specific Q-
binding sites conflicts with the idea of the pool function of ubiquinone. Although it has 
been proposed that the bound quinone may be in equilibrium with the pool by very fast 
association-dissociation, there is some uncertainty over how ubiquinone functions as both 
a mobile pool and protein-bound prosthetic group. To reconcile these two aspects of the 
functions of ubiquinone, a new approach to the process of Q-binding to the mitochondrial 
ubiquinol-cytochrome c reductase by certain spectroscopically labeled ubiquinone 
derivatives is obviously needed. 
Recently, the introduction of the 19p NMR techniques in biochemistry has opened 
a significant new approaches for highly sensitive investigations of the molecular order and 
dynamics in model and biological membranes (131), lipid-lipid and protein-lipid 
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interactions (132-134), substrate-enzyme binding (24, 135) and enzyme-enzyme 
interaction (136). The change of relaxation time T 1 and line broadening can give some 
84 
information about the ordering of molecules and the interaction between the substrate and 
enzyme. The use of fluorine as a spectroscopic label has several advantages. First, the 
sensitivity of 19F NMR is relatively high, 83% of that of 1 H NMR which can meet the 
requirement of dilute conditions. Second, since 19p is not normally present in biological 
systems, the spectra are generally simple. Third, the chemical shifts of 19f NMR are 
large and are much more sensitive to chemical environments which makes it very suitable 
for use as a probe. 
As a qualified biological probe of Q-binding, the labeled analogues of ubiquinone 
must possess properties that the ubiquinone has, or that they must be competitive 
inhibitors of ubiquinol-cytochrome c reductase for Q-binding. In order to directly examine 
the property of Q-binding in ubiquinol-cytochrome c reductase by 19p NMR 
spectroscopy, three fluoro-ubiquinone derivatives, 2,3-dirnethoxy-6-(9'-fluorodecyl)-5-
methyl-1,4-benzoquinone (9'FQ), 6-decyl-2-methoxy-5-trifluoromethyl-1,4-
benzoquinone (TFQ) and 6-(9'-fluorodecyl)-2-methoxy-5-trifluiromethyl-1,4-
benzoquinone (9'FfFQ), have been synthesized and their biological properties have been 
studied. 
Experimental Procedures 
Materials 
a,a,a-Trifluoro-p-cresol were from Aldrich; cytochrome c from Sigma; silica G 
thin layer plates from Analtech; 2,3-dirnethoxy-5-methyl-6-geranyl-1 ,4-benzoquinone 
(Q2) and its reduced form (Q2H2) were synthesized as previously reported (106). 
Enzyme Prf4>arations 
Succinate-ubiquinone reductase (107), succinate-cytochrome c reductase (107), 
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cytochrome c reductase (107) and the ubiquinone-, phospholipid(PL)-depleted succinate-
cytochrome c reductase (137), ubiqunol-cytochrome c reductase (107) were prepared as 
previously reported. 
Spectral Measurements 
The absorption spectra were measured in a Cary spectrometer, model219, or DW 
2000 spectrophotometer. Both 1 H NMR and 19fNMR spectra were measured with a 
Varian XL-300 NMR spectrometer. The instrument settings for 19p NMR measurement 
were: spectral width, 39840 Hz; 77° pulse; delay time, 0.65 s; acquisition time, 0.35s. A 
standard 2 pulse sequence (S2PUL) was used and the data was gathered with a 16K data 
set. The molecular weight was determined with a TS-250 mass spectrometer. 
Synthesis of 2.3-Dimethoxy-6-(9'-fluoro<iecyD-
5-methyl-1.4-benzoquinone 
The total synthesis pathway of 2,3-dimethoxy-6-(9'-fluorodecyl)-1 ,4-
benzoquinone is shown in scheme 4. Since 2,3-dimethoxy-5-methyl-1,4-benzoquinone 
(Qo) is commercially available, the synthesis simply became the preparation ofbis(10-
fluoroundecanoyl)peroxide. To synthesize the diacyl peroxide, it was started with 10-
undecenoic acid, which underwent hydrogen fluorination of the double bound, conversion 
of the fluoroundecahoic acid to the acyl chloride and the oxidation of acyl chloride to 
diacyl peroxide. The procedure for alkylation of Qo is a standard method in the 
preparation of alkylated Q derivatives. 
Syntbesis of 10-Fluoroundecanoic acid <142). In a 200 ml Teflon container was 
placed 100 m1 of 70% hydrogen fluoride/pyridine solution. To this solution was added 
18.5 g of tO-undecylenic acid at 0 °C. The reaction mixture was stirred for 50 minutes at 
SCHEME 4 
1HE SYNTHESIS OF 2,3-DIMETifOXY-6-(9'-FLUORODECYL)-
5-MElHYL-1 ,4-BENZOQUINONE 
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the same temperature, then it was diluted with 200 ml of ice-water and extracted with 
chloroform. The extract was washed with water and dried over anhydrous sodium 
sulfate. After the solvent was removed, a pale yellow oil was obtained. The crude 
product was then purified by two crystallizations with petroleum ether (30-60 °C). 10-
Fluoroundecanoic acid (12 g) was obtained. lH NMR (CDCl3), 0.95 (q,3H), 1.33 
(m,8H), 1.45 (m,2H), 1.62 (m,4H), 2.34 (t,2H), 4.64 (m,lH). 
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Synthesis ofBisClO-fluoroundecauoyl)peroxide. 10-Fluoroundecanoic acid (10 
g)was mixed with 20 m1 of thionyl chloride and the mixture was refluxed for 1.5 hours. 
The excess thionyl chloride was then removed by vacuum evaporation. A yellow oil was 
obtained and transferred to a 250 ml three necked flask equipped with stirrer and 
thermometer. 150 m1 of ether was added to dissolve the oil. The solution was cooled to 0 
oc and 15 m1 of hydrogen peroxide (65%) was added dropwise at 0 °C with stirring. To 
this mixture was added 10 ml of pyridine ~ 2 hours at the same temperature with vigorous 
stirring. The mixture was stirred another hour at room temperature. The product was 
extracted with ether. The extract was washed in sequence with water, IN hydrochloric 
acid, 5% sodium bicarbonate, water, and dried over anhydrous sodium sulfate. After the 
ether was removed, 7 g of pale yellow oil was obtained. lH NMR (CDCl3), 0.91 (q,6H), 
1.25 (m,20H), 1.65 (m,8H), 2.39 (t,4H), 4.65 (m,2H). 
Synthesis of 2.3-Dimethoxy-6-C9'-tluorodecyn-5-methyl-1.4-benzoquinone. Qo 
( 40 mg) was dissolved in 2 ml of benzene in a 10 ml Enrlymeyer flask. To this solution 
was added 120 mg of bis(lO-fluoroundecanoyl) peroxide and refluxed for 3 hours. The 
product was directly separated by TLC developed with a mixed solvent of hexane and 
i 
ether (3.5:1). 2,3-Dimethoxy-6-(9'-fluorodecyl)-5-methyl-1,4-benzoquinone (10 mg, 
Rr-0.7) was obtained. It shows UV EtOH pxid. 276 nm, red. 288 nm; MW.340; 1 H 
NMR (CDCl3), 0.95 (q,3H), 1.31 (m,l2H), 1.59 (m,2H), 1.98 (s,3H), 2.45 (t,2H), 
3.97 (s,6H), 4.63 (m,lH) and 19p NMR (CDCl3), -99.2 ppm (m) (Ref. TFA). 
Synthesis of 6-Decyl-2-methoxy-5-trifluoromethyl-
1.4-benzOQYinone 
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The synthesis of 6-decy 1-2-methoxy-5-trifluoromethy 1-1,4-benzoquinone was 
started with commercially available 2,2,2~tifluoro-p-cresol, and the total pathway of the 
synthesis is shown in scheme 5. 
Synthesis ofp;Trifluorometbylanisole 038). 2,2,2-Trifluoro-p-cresol (20 g) 
was dissolved in 200 m1 of acetone at room temperature in a 500 m1 Erlenmeyer flask. 
Anhydrous potassium carbonate (18 g) was added into this solution followed by the 
addition of 28 g (14 ml) of iodomethane with stirring, and the reaction mixture was heated 
with a hot water bath and allowed to reflux for 6 hours. Following the acetone removal by 
distillation, the residue was mixed with water and extracted with ether, washed with water 
and dried over anhydrous magnesium sulfate. The ether was removed by vacuum 
evaporation and p-trifluoromethylanisole (17.3 g) was obtained by vacuum distillation as a 
colorless liquid (80°C at 30 mm). Yield, 80%; lH NMR (CDCl3), 3.84 (s,3H), 6.96 
(d,2H), 7.54 (d,2H) 
Synthesis of 2-Njtro-4-trifluorometbylanisole. p-Trifluoromethylanisole (17.3 g) 
was dissolved in 36 m1 of carbon tetrachloride in a 250 m1 three necked flask equipped 
with a stirrer and thermometer. The solution was cooled to 5°C and 36 m1 of 90% nitric 
acid was added dropwise at 5 c in 30 minutes. After stirred at 10-15°C for 1 hour, the 
mixture was then poured onto 400 g of ice and extracted with chloroform. The extract 
was washed with water and dried over anhydrous magnesium sulfate. After the solvent 
was removed by vacuum evaporation, the residue (16.5 g) was crystalized from 30-60 c 
petroleum ether (200 ml). A yellow flat crystal of 2-nitro-4-trifluoromethylanisole (15.4 
g) was obtained. Yield, 71%; 1H NMR (CDCl3), 4.04 (s,3H), 7.21 (d, lH), 7.80 
(q,lH), 8.13 (d,lH) 
0 
OH 
H2, Pd/C 
SCHEME 5 
1HE SYN1HESIS OF 6-DECYL-2-METIIOXY -5-
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Synthesis of 2-Amino-4-trifluoromethylaoisole. 2-Nitro-4-trifluoromethylanisole 
(5 g) was dissolved in 70 rn1 of CH30H-HCl in 500 rn1 hydrogenation bottle. 0.5 g of 
Pd/C catalyst was suspended in the solution. Mter the oxygen in the reactor was 
removed, the hydrogenation was started. The reaction was completed when no hydrogen 
absorption was observed. The methanol was removed by vacuum evaporation. The 
residue was neutralized with 1 N of sodium hydroxide and extracted with ether. The 
extract was washed with water and dried over anhydrous magnesium sulfate. After the 
ether was removed, the residue was crystalized from 80 m1 of 30-60°C petroleum ether. 
3.5 g of pale yellow flat crystalline 2-amino-4-trifluoromethylanisole was obtained. Yield, 
81 %; 1 H NMR (CDCl3), 3.89 (s,3H), 3.93 (s,2H), 6.82 (d,lH), 6.92 (d,lH), 7.00 
(q,1H) 
Synthesis of 2-Acetylamido-4-trifluQrQmethylanisole. 2-Amino-4-
trifluoromethylanisole (2 g) was dissolved in 6 rn1 of acetic anhydride in a 25 rn1 
Erlenmeyer flask. The reaction mixture was refluxed for 1 hour and was mixed with 50 
m1 of water, extracted with ether. The extract was washed two times with water, 1% of 
sodium bicarbonate and water subsequently and dried over anhydrous magnesium sulfate. 
I 
After the ether was removed, 2.3 g of white crystalline 2-acetylarnido-4-
trifluoromethylanisole was obtained. Yield, 96%; 1 H NMR (CDCI3), 2.28 (s,3H), 3.89 
(s,3H), 7.09 (d,lH), 7.39 (d,1H), 7.67 (q, 1H), 7.80 (s,1H). 
Synthesis Qf 2-Acety lamido-S-nitrQ-4-trifluoromethylanisQle. 2-Acety lamido-4-
trifluoromethylanisole (2.3 g) was dissolved in 75 m1 of carbon tetrachloride in a 250 rn1 
three necked flask equipped with stirrer and thermometer. The solution was cooled to soc 
and to it was added 8 rn1 of nitric acid (9S%) dropwise at such a rate to maintain the 
temperature at S°C. Then the mixture was stirred 1 hour at l0°C. The aqueous layer was 
separated and poured onto 200 g of ice. The yellow precipitate was filtered out, washed 
with water and dried at room temperature. The crude product was suspended in 10 m1 of 
--------
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hot carbon tetrachloride, the insoluble solid was filtered out and washed three times with 
hot carbon tetrachloride. A white powder of 2-acetylamido-5-nitro-4-
trifluoromethylanisole (1.4 g) was obtained. Yield, 52%; 1 H NMR (CDCl3), 2.27 
(s,3H), 4.04 (s,3H), 7.47 (s,1H), 7.90 (s,1H), 8.97 (s,1H). 
Synthesis of 2-Arnino-5-nitro-4-trlfluoromethylanisole. 2-Acetylamido-5-nitro-
4-trifluoromethylanisole (1.4 g) was dissolved in 1.75 m1 of Claison alkali (139) 
(prepared by dissolving 88 g of potassium hydroxide in 63 m1 of water, cooling, and 
diluting to 250 m1 with methanol). The reaction mixture was heated on a boiling water 
bath for 15 minutes. Then 1. 75 m1 of hot water was added to the mixture and heated for 5 
' 
minutes at the same temperature. The pr~uct was extracted with ether. The extract was 
washed with water and dried over anhydrous magnesium sulfate. The ether was removed 
: 
by evaporation and 1 g of yellow solid pr~uct was obtained. Yield, 83%; 
1H NMR (CDCl3), 3.98 (s,3H), 4.60 (s,t2H), 6.99 (s,1H), 7.55 (s,1H). 
Synthesis of 2.5-Diamino-4-triflUoromethylanisole. 2-Amino-5-nitro-4-
trifluoromethylanisole (1 g) was dissolved'in 10 m1 of methanol. To this solution were 
added 10 m1 of concentrated hydrochloric acid and 5 g of anhydrous tin (II) chloride 
subsequently. The mixture was refluxed for 10 minutes and then made to strongly basic 
with 20% sodium hydroxide. The product was extracted with ether. The extract was 
washed with water and dried over anhydrous magnesium sulfate. The ether was removed 
by vacuum evaporation and 0.8 g of pale yellow solid 2,5-diamino-4-
trifluoromethylanisole was obtained. Yield, 92%; 1H NMR (CDCl3), 3.49 (s,2H), 3.79 
(s,2H),3.82 (s,3H), 6.20 (d,1H), 6.78 (d,1H). 
Synthesis of 2-Methoxy-5-trifluoromethyl-1 .4-benzOQ.uinone Cl4Q). 2,5-
Diamino-4-trifluoromethylanisole (0.4 g) was mixed with a solution of 2.5 m1 of 
concentrated sulfuric acid in 7.8 m1 of water in a 50 m1 three necked flask equipped with 
stirrer and thermometer. 7.8 m1 of benzene was added into the flask. The two layer 
solution obtained was cooled to 8 oc and 0. 7 g of sodium dichromate in 1.4 ml of water 
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was added dropwise with vigorous stirring at such a rate as to maintain the temperature not 
higher than 10 °C. After the addition of sodium dichromate, the mixture was stirred for 2 
hours at 10 °C. The product was extracted with ether. The extract was dried over 
anhydrous magnesium sulfate. After the ether was removed, a dark solid residue was 
obtained, which was subjected to a TLC separation developed with a mixed solvent of 
hexane and ether (1:1, V/V). A dark green solid (yellow in solution) of2-methoxy-5-
trifluoromethyl-1,4 benzoquinone (28 mg; Rr-0.3 )was obtained. Yield, 7%; 1H NMR 
(CDCl3), 3.98 (s,3H), 6.05 (s,1H), 7.06 (m,1H); uvEtOH oxid. 244 nm, red. 297 nm. 
Synthesis of 6-Decyl-2-methoxy-5-trifluoromethyl-1.4-benZOQ.yinone. 2· 
Methoxy-5-trifluoromethyl-1,~benzoquinone (20 mg) was dissolved in 2 m1 of benzene 
in a 10 ml Erlenmeyer flask. 20 mg of diuJ1,decanoyl peroxide was added to this solution. 
The reaction mixture was refluxed for 4 hours. The product ( 4 mg, Rr-0.5) was directly 
isolated with TLC developed with a mixed 1solvent of hexane and ether (1:1 VN). It 
shows UV EtOH oxid. 264 nm, red. 296 mn; MW. 346; and lH NMR (CDCl3), 0.88 (t, 
3H), 1.26 (m,l4H), 1.40 (m,2H), 2.72 (t,:2H), 3.84 (s,3H), 5.97 (s, lH). For 19p 
NMR study further purification with TLC was needed. The chemical shift of its 19p 
NMR (CDCI3) is +15.4 ppm (ref. TFA). 
Synthesis of 6-(9'-FlyorodecyD-2-methoxy-
5-trifluorornethyl-1.4-benzwinone 
6-(9'-Fluorodecyl)-2-methoxy-5-trifl.uoromethyl-1,4-benzoquinone was prepared 
by the alkylation of 2-methoxy-5-trifluoromethyl-1,4-benzoquinone as shown in Scheme 
6. Thus, 2-methoxy-5-trifluoromethyl-1,4-benzoquinone (40 mg) was dissolved in 2 m1 
of benzene. To this solution was added 80 mg of bis(10-fluoroundecanoyl)-peroxide. The 
reaction mixture was refluxed for three hours. 6-(9'-Fluorodecyl)-2-methoxy-5-
trifluoromethyl-1,4-benzoquinone(lO mg, RF0.6) was directly separated by TLC 
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developed with a mixed solvent of hexane and ether (1:1). It shows UV EtOH oxid. 264 
nm, red.296 nm; MW. 364; 1H NMR, 0.95 (q,3H), 1.35 (m,12H), 1.57 (m,2H), 2.52 
(t,2H), 3.84 (s,3H), 4.64 (m,1H), 5.96 (s.1H) and 19p NMR (CDCl3), +15.4 ppm (s), 
-99.2 ppm (m) (Ref. TFA). 
Results and Discussion 
Synthesis ofFluoroubiQ.uinone Derivatives 
The molecule of ubiquinone can be divided into two parts, the benzoquinone ring 
and the side chain at position 6. The benzoquinone ring is directly involved in the electron 
transfer reactions and the side chain plays an important role in its function ( 1 06). 
Photoaffinity labeling of ubiquinol-cytochrome c reductase indicated that two protein 
subunits <Mr 1700 and 37000) were heavily labeled when either azido-Q (Chapter IT) or 
arylazido-Q (61) was used. Although the location of the photoactivable azido group in the 
arylazido-Q is more than 15 carbons away from the benzoquinone ring, it labeled the same 
protein subunits as did the azido-Q in which the azido group is located on the 
benzoquinone ring. To study the interaction between ubiquinone and ubiquinol-
cytochrome c reductase, as well as the difference of the functions of ubiquinone ring and 
the side chain in the interaction with ubiquinol-cytochrome c reductase, two kind of 
fluoro-Q derivatives, one with the fluoro group on the ubiquinone ring and another with 
the fluoro group on the side chain, are needed. 
In the synthesis of 9'FQ, most of the work was the preparation of bis(lO-
fluoroundecanoyl)peroxide and the yield was relatively high. However, in the reaction of 
the conversion of 10-fluoroundecanoic acid to the acid chloride careful control of the 
reaction temperature is essential. When the reaction temperature was higher than 100 °C, 
SCHEME 6 
TilE SYNTHESIS OF 6-(9'-FLUORODECYL)-2-METHOXY-
5-TRIFLUOROMETHYL-1,4-BENZOQUJNONE 
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elemination ofhydrofluoride was observed. In contrast, if the temperature is too low, the 
acid could not be completely converted to acid chloride . The unreacted acid could be 
oxidized to peracid by hydrogen peroxide in the next reaction step, which would destroy 
Qo in the reaction of the alkylation of Qo. Therefore, using a gentlly boiling water bath 
for the chlorination is recommended. 
Most of the reactions of the preparation of 2-methoxy-5-trifluoromethyl-1 ,4-
benzoquinone are typical reactions of aromatic compounds. The yields are relatively high 
except for the oxidation of 2,5-diamino-5-trifluoromethylanisole (10% ). 
The yield of the alkylation of 2-methoxy-5-trifluoromethyl-1 ,4-benzoquinone was 
not very high. Usually, to carry out the alkylation reaction ofQo, an excess of diacyl 
peroxide should be used (3: 1 mol/mol) to get a higher yield. However, in our case excess 
diacyl peroxide could not be used. If excess diacyl peroxide was used, 3,6-didecyl-2-
methoxy-5-trifluoromethyl-1,4-benzothiazole would be produced. Fortunately, the 
unreacted 2-methoxy-5-trifluoromethyl-1,4-benzoquinone could be recovered. Therefore, 
the yield based on the consumption of 2-methoxy-5-trifluoromethyl-1,4-benzoquinone 
was higher than 30%. 
Biolo&ical PrQperties ofFluoroubiquinone Derivatives 
As expected, replacement of a hydrogen with a fluorine on the side chain of 
ubiquinone did not affect its biological activity too much. 9'-FQ shows relatively high 
activity as an electron acceptor, donor and mediator assayed with succinate-ubiquinone 
reductase (SQR) (Fig. 24), ubiquinol-cytochrome c reductase (QCR) (Fig, 25) and 
ubiquinone and phospholipid depleted succinate-cytochrome c reductase (dSCR) (Fig. 
26), respectively. The activity of the ubiquihone derivatives with fluorine on the 
benzoquinone ring is changed significantly. Both 6-decyl-2-methoxy-5-trifluoromethyl-
1 ,4-benzoquinone and 6-(9'-fluorodecyl)-2-methoxy-5-trifluoromethyl-1 ,4-benzoquinone 
have activity as electron acceptors (Fig, 24), but have no activity as electron donors and 
mediators at all. The reason is probably that the trifluoromethyl group, as a strong 
electron withdrawing group, makes the benzoquinone ring very electron deficient and 
increases its midpoint potential (about 50 m V higher than that of Q2). Therefore, these 
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two fluoro ubiquinone derivatives can be reduced, but are hard to be oxidized. As a 
result, they can only serve as electron acceptors for SQR (Fig. 24) and do not show any 
activity as electron donors and mediators ~or QCR and succinate-cytochrome c reductase 
(SCR). Interestingly, they show inhibitory properties on dSCR (Fig. 27) and QCR (Fig. 
28). The maximum inhibition can be reached if 36 fold excess fluoroubiquinone (to 
cytochrome b) is incubated with dSCR (85% inhibition for SCR and 70% for QCR). If 
intact SCR was used, 60% activity was inhibited indicating that the binding of between the 
intrinsic Q and the enzyme is stronger than that between these two fluoro-Q and the 
enzyme. Kinetic studies indicate that these two·fluoroubiquinones are competitive 
inhibitors (Fig.29). As a competitive inhibitor, it must bind to the same site(s) as the 
ubiquinone does. It is obvious that these two fluoroubiquinones are qualified candidates 
as molecular probes to monitor the process of Q binding in ubiquinol-cytochrome c 
reductase. Of course 9'-FQ is also a good candidate because it is biological active. 
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Fig. 24. Fluoro-Q Derivatives Function as Electron Acceptors. 3 J..Ll of succinate-
ubiquinone reductase (1 mg/ml) and different amounts of Q2 ( -0-), 9'FQ 
( -0-), TFQ ( -~-), and 9'FfFQ ( -~-) as indicated in the figure were used 
for SQR activity assay. All the activities were related to the maximum SQR 
activity when Q2 was used. 
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Fig. 25. 9'FQ Functions as Electron Donor Assayed with QCR. The QCR activity was 
assayed with different amount of QoCwBr(H2) (-0-) and 9'FQ (-~-). The 
activities were related to the maximum QCR activity when QoCwBr(H2) was 
used. 
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Fig. 26. Fluoro-Q Derivatives Function as Electron Mediators. 100 ~ aliquots of d-SCR 
( 1.4 mg/ml, in 50 mM K/K phosphate buffer containing 10% glycerol and 
0.5% sodium cholate, pH 7 . .4) was incubated with different amount of Q2 
( -o-) and 9'FQ ( -o-) in 5 J.ll ehtanol as indicated in the figure for 10 min. at 0 
·c. To each of these mixtures were added 7 J.ll of asolectin (10 mg/ml) and 
then incubated for 60 min. at 0 ·c. 3 J.ll aliquots of each sample was used for 
SCR activity assay. 
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Fig. 27. The Inhibition of Reconstituted SCR by TFQ (-.1-) and 9'FTFQ (-o-). 100 )ll 
aliquots of d-SCR (2 mg/ml, in the same buffer as in that of fig. 23) were 
incubated with different amount of fluoro-Q in 3 Jll of ethanol as indicated in 
the figure for 10 min. at 0 oc and then incubated with 3 Jll of 5 mM Q2 for 10 
min. at the same temperature. To each sample was added 10 )ll of asolectin 
(10 mg/ml). 3 Jll aliquots of each sample were used for SCR activity assay. 
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Fig. 28. The Inhibition ofQCR Activity by TFQ Assayed with Reconstituted SCR. 100 
J.Ll aliquots of d,..SCR (2 mg/nil, in the same buffer mentioned before) were 
incubated with different amount of the TFQ in 3 J.Ll of ethanol as indicated in 
the figure for 10 min. at 0 oc and then incubated with 3 J.Ll of Q2 (5 mM in 
ethanol) for 10 min.at the same temperature. To each sample was added 10 J.Ll 
of asolectin and incubated for 60 min. at 0 °C. 1 J.Ll aliquots were used for 
QCR activity assay. 
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Fig. 29. Double Reciprocal Plot of the Oxidation Rate of ~H2 Catalyzed by QCR 
at the Presence ofTFQ .. The reaction valocity was measured when 
different amount Q2H2 was used without TFQ (-o-) or with 5 nmoles 
ofTFQ (-o-) or with 10 nmoles ofTFQ. TFQ and Q2H2 were 
dissolved in the assay mixture ftrst. 3 J.ll QCR (0.04 mg/ml) was used 
for QCR activity assay. , 
CHAPTER V 
SUMMARY AND CONCLUSIONS 
Ubiquinone (Q), especially its protein-binding form, plays an essential role in 
electron transfer and proton translocation in ubiquinol-cytochrome c reductase. 
Understanding of the interaction of ubiquinone with proteins of ubiquinol-cytochrome c 
reductase has become the key point for studying the mechanism of energy conservation in 
site II. One of the best ways for studying the interaction between ubiquinone and its 
binding proteins is the use of ubiquinone analogues or its Q-like inhibitors with reporting 
group which can be monitored or detected during or after reaction with ubiquinol-
cytochrome c reductase. The interactions of ubiquinol-cytochrome c reductase with 
photoactivable 3-azido-2-methy 1-5-methoxy-6-(3', 7' -dimethylocty 1 )-1 ,4-benzoquinone, 
and with photoactivable Q-like inhibitor, 6-azido-5-undecyl-4,7-dioxobenzothiazole, were 
tested. Some 19p NMR spectroscopically detectable fluoro substituted ubiquinone 
derivatives have been synthesized. 
2-Azido-2-methyl-5-methoxy-6-(3',7'-dimethyloctyl)-1,4 benzoquinone (azido-Q) 
was found to be suitable for the study of specific interactions between ubiquinone (azido-
Q) and proteins. It showed partial efficiency in restoring activity to the Q- and treated 
reductase, however, became completely inactivated upon photolysis and the inactivation 
was not reversed by addition of ubiquinone derivatives. Two protein subunits with 
Mr=37 ,000 and 17,000 were fond to be heavily labeled when depleted ubiquinol-
cytochrome c reductae was treatd with [3H]azido-Q followed by photolysis and SDS-
PAGE. The amount of radioactive labeling of the Mr= 17,000 subunit was proportional to 
the degree of inactivation and was affected by the presence of phospholipid. The 
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radioactive labeling fo the Mr=37 ,000 subunit, however, showed no correlation with the 
degree of inactivation. Since the radio labeling at the Mr= 17,000 subunit was affected by 
phospholipid and correlated with the enzymatic activity, this subunit is probably the Q-
binding protein in this enzyme complex. The distribution of radioactivity among the 
subunits of ubiquinol-cytochrome c reductase was not affected by the presence of 
antimycin A, 5-undecyl-6-hydroxy-4,7-dioxobenzothiazole (UHDBT) or n-heptyl-4-
hydroxyquinoline-N-oxide, suggesting that the binding site(s) of the inhibitors were not 
the Q-binding site(s). 
Further study of the inhibitory effiect of a series of synthesized UHDBT derivatives 
' 
on ubiquinol-cytochrome c reductase found that the 6-hydroxyl and 2-hydrogen groups of 
UHDBT are not structural requirements for inhibition and 6-azido-5-(1',2'-3H-undecyl)-
4,7-dioxobenzothiazole ([3H]6-azido-UDBT) is suitable for the study of the UHDBT-
binding in ubiquinol-cytochrome c reductase. When the photolyzed, [3H]6-azido-UDBT 
treated ubiquinol-cytochrome c reductase, was subjected to organic solvent extraction, no 
I 
radioactivity was found in the reductase Jirotein. Rather, the radioactivity was located in 
the phospholipid fraction which was identified to be a [3H]azido-UDBT-cardiolipin 
adduct. This suggests that the inhibition by UHDBT is due to perturbation of a specific 
cardiolipin molecule in ubiquinol-cytocluiome c reductase. Since UHDBT and 6-azido-
UDBT also inhibit the enzymatic activity pf delipidated reductase (10% of the original lipid 
remained) assayed after reconstruction with ubiquinone and phospholipid, and the 
[3H]azido-UDBT was also covalently linked to the cardiolipin molecule after the azido-
UDBT treated delipidated ubiquinol-cyt~hrome c reductase was photolyzed, the UHDBT 
perturbated cardiolipin molecule is structurally indispensable to the reductase and tightly 
bound to the reductase proteins, most likdy the Q-binding proteins. 
Three fluoro substituted ubiquinone derivatives, 2,3-dimethoxy-6-(9'-
fluorodecyl)-5-methyl-1,4-benzoquinone, 6-decyl-2-methoxy-5-trifluoromethyl-1,4-
benzoquinone and 6-(9'-fluorodecyl)-2-methoxy-5-trifluoromethyl-1 ,4-benzoquinone, 
105 
have been synthesized. As expected, 2,3-dimethoxy-6-(9'-fluorodecyl)-5-methyl-1 ,4-
benzoquinone was a ubiquinone analogue and possessed all the biological properties that 
Q2 had. The other two fluoro-Q derivatives, however, showed potent inhibition on 
ubiquinol-cytochrome c reductase and kinetic study revealed that they were competitive 
inhibitors. Since they were active analogues of ubiquinone or ocmpetitive inhibitors for 
ubiquinone, all the three fluoro-Q derivatives are valuable probes for Q-binding. 
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